CA2058350C - Composite intraocular lens and method of manufacture - Google Patents
Composite intraocular lens and method of manufacture Download PDFInfo
- Publication number
- CA2058350C CA2058350C CA002058350A CA2058350A CA2058350C CA 2058350 C CA2058350 C CA 2058350C CA 002058350 A CA002058350 A CA 002058350A CA 2058350 A CA2058350 A CA 2058350A CA 2058350 C CA2058350 C CA 2058350C
- Authority
- CA
- Canada
- Prior art keywords
- intraocular lens
- methacrylate
- lens
- core
- optic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1616—Pseudo-accommodative, e.g. multifocal or enabling monovision
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
- A61F2002/16905—Having means on lens to reduce overall dimension of lens for insertion into small incision
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Abstract
The new intraocular lens of the present invention is a one-piece composite lens having a soft, foldable central optic region and a hard, non-foldable outer peripheral region making up the haptics or legs of the intraocular lens. The soft, central optic portion of the lens is typically manufactured from a material capable of being folded so that the intraocular lens can be inserted through a small incision on the order of 3 to 4 mm. The hard haptic portion of the lens provides support for the lens in the eye after insertion and unfolding of the lens. The relatively rigid plastic lends support to the entire lens structure after its insertion into the posterior chamber of the eye, and tends to help stabilize the position of the lens after insertion and the closure of the incision. A preferred material of the soft optical region being a poly(hydroxyethyl methacrylate) or pHEMA
or a copolymer thereof such as HEMA and 6-hydroxyhexyl methacrylate (HOHEXMA) or p(HEMA-co-HOHEXMA). The preferred material of the hard haptic region being made from a relatively hard plastic, such as (polymethyl methacrylate) or PMMA, or a copolymer thereof.
or a copolymer thereof such as HEMA and 6-hydroxyhexyl methacrylate (HOHEXMA) or p(HEMA-co-HOHEXMA). The preferred material of the hard haptic region being made from a relatively hard plastic, such as (polymethyl methacrylate) or PMMA, or a copolymer thereof.
Description
2~~r~~~~
Case No. 37.,148 COMPOSITE INTRAOCULAR hENS
AND METHOD OF MANUFACTURE
EACKGROUND OF THE INVENTION .
This invention relates to intraocular lenses and, more particularly, to composite intraocular lenses which are foldable so as to be insertable through a small incision of appro~cimately 3 to 4 millimeters (mm) .
The natural aye, in humans and most, if not all, animals, contains a lens located internally which la focuses images on the retina. Either through disease or other naturally occurring processes, or mutations, the lens may fail to function properly. For instance, the lens, by mutation, may have been eliminated from the eye during its formation at birth. Or the lens may be cloudy at birth, or become cloudy over time. This clouding of the lens is known as a cataract, which inhibits the transmission of visual information through the lens to the retina.
The removal of diseased natuxal lenses has, prior to the advent of intraocular lenses, required a large incision into the eye at the function of the cornea and the sclera in order to remove the lens. The healing time in such an operation was substantial and 20~~~~0 the pain was severe. No lens was inserted in place of the natural lens and eyeglasses or external-type contact lenses were employed to help correct restored vision to the patient.
The advent of intraocular lenses, along with the instruments needed to insert them, was a helpful innovation. Surgical incisions were still relatively large, on the oxder of 10-14 millimeters (mm), and healing time remained 'substantial: however, this incision length was required for the cataract removal operation, whereas intraocular lens implants required only a 6 or 7 mm incision for their insertion.
More recently, the cataract extraction operation performed by ultrasonic destruction and suction (phacaemulsification) has been developed and allows the removal of the cataract through an incision as small as 3 mm. However, presently this incision must then be enlarged from 5 to 7 mm for insertion of the intraocular lens implant. Experience has shown that the longer the incision, the longer it takes to heal, the greater the danger of rupture of the incision postoperatively, and the greater the danger that scar tissue, which forms during the healing process, will interfere with the patient's vision. Furthermore, the longer the incision and resultant scar, the greater the danger that post-operative astigmatism will occur due to uncontrolled healing of the eye tissue. zt is therefore desirable to develop an intraocular lens implant capable of being inserted through an incision not greater than that which is necessary for cataract extraction, i.e., 3 mm.
One proposal for reducing the length of the incisian requires the use of a very soft material for the lens, soft enough to permit the lens to be folded, inserted throLagh the incision, and released. One such i I
Case No. 37.,148 COMPOSITE INTRAOCULAR hENS
AND METHOD OF MANUFACTURE
EACKGROUND OF THE INVENTION .
This invention relates to intraocular lenses and, more particularly, to composite intraocular lenses which are foldable so as to be insertable through a small incision of appro~cimately 3 to 4 millimeters (mm) .
The natural aye, in humans and most, if not all, animals, contains a lens located internally which la focuses images on the retina. Either through disease or other naturally occurring processes, or mutations, the lens may fail to function properly. For instance, the lens, by mutation, may have been eliminated from the eye during its formation at birth. Or the lens may be cloudy at birth, or become cloudy over time. This clouding of the lens is known as a cataract, which inhibits the transmission of visual information through the lens to the retina.
The removal of diseased natuxal lenses has, prior to the advent of intraocular lenses, required a large incision into the eye at the function of the cornea and the sclera in order to remove the lens. The healing time in such an operation was substantial and 20~~~~0 the pain was severe. No lens was inserted in place of the natural lens and eyeglasses or external-type contact lenses were employed to help correct restored vision to the patient.
The advent of intraocular lenses, along with the instruments needed to insert them, was a helpful innovation. Surgical incisions were still relatively large, on the oxder of 10-14 millimeters (mm), and healing time remained 'substantial: however, this incision length was required for the cataract removal operation, whereas intraocular lens implants required only a 6 or 7 mm incision for their insertion.
More recently, the cataract extraction operation performed by ultrasonic destruction and suction (phacaemulsification) has been developed and allows the removal of the cataract through an incision as small as 3 mm. However, presently this incision must then be enlarged from 5 to 7 mm for insertion of the intraocular lens implant. Experience has shown that the longer the incision, the longer it takes to heal, the greater the danger of rupture of the incision postoperatively, and the greater the danger that scar tissue, which forms during the healing process, will interfere with the patient's vision. Furthermore, the longer the incision and resultant scar, the greater the danger that post-operative astigmatism will occur due to uncontrolled healing of the eye tissue. zt is therefore desirable to develop an intraocular lens implant capable of being inserted through an incision not greater than that which is necessary for cataract extraction, i.e., 3 mm.
One proposal for reducing the length of the incisian requires the use of a very soft material for the lens, soft enough to permit the lens to be folded, inserted throLagh the incision, and released. One such i I
material is silicone; however, a lens made from sili-cone is so extremely soft that, as a result, when the lens and its haptics are permitted to unfold in the eye, the almost jelly-like softness of the lens makes it difficult for the surgeon to properly position the lens in the eye. The jelly-like softness of the silicone lens does not provide sufficient rigidity for the lens after insertion and, as the lens moves about, the optical integrity of the Lens may thereafter be l0 affected. In addition, the jelly-like softness of this lens makes it difficult to insert, unfold and position the lens via its haptics in the posterior chamber of the eye. It is the posterior chamber into which most intraocular lenses are placed, as it is behind the iris, like the natural lens it replaces.
Furthermore, there is often a compressive force exerted on the lens by ocular structures follow-ing surgery, and these can, and have resulted in deformation of fhe soft lens and haptics to cause reduced vision in the patent. One of these potentially compressing structures, the lens capsule, surrounds the human lens entirely. It is common practice for the lens implant to be intentionally placed within the capsule following the removal of the cloudy lens or cataract from within the capsule. This is widely.
accepted to be a preferred method for securing the lens implant as great stability is afforded the implant, and its position within the capsule prevents the implant from contacting more delicate ocular structures.
Silicone lenses are, however, not recommended for this type of placement within the capsule as the compressive forces from the capsule can produce lens distortion and reduced vision following surgery.
I ~I I
Furthermore, there is often a compressive force exerted on the lens by ocular structures follow-ing surgery, and these can, and have resulted in deformation of fhe soft lens and haptics to cause reduced vision in the patent. One of these potentially compressing structures, the lens capsule, surrounds the human lens entirely. It is common practice for the lens implant to be intentionally placed within the capsule following the removal of the cloudy lens or cataract from within the capsule. This is widely.
accepted to be a preferred method for securing the lens implant as great stability is afforded the implant, and its position within the capsule prevents the implant from contacting more delicate ocular structures.
Silicone lenses are, however, not recommended for this type of placement within the capsule as the compressive forces from the capsule can produce lens distortion and reduced vision following surgery.
I ~I I
SUMMARY OF THE INVENTION
The invention provides a one-piece, small-incision intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion. This invention also provides a novel polymer composition for an intraocular lens utilizing two dissimilar polymeric materials to form a one-piece intraocular lens. This invention also provides a one-piece intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion while providing excellent biocompatibility with the patient's eye. Further, the invention provides a one-piece intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion wherein the stiff haptic portion has a further soft material at its terminus to protect the eye tissues at the point of contact without sacrificing the lens positioning properties of stiff haptics. This invention also provides a method of making a one-piece intraocular lens utilizing two dissimilar polymeric materials wherein one polymeric material is soft enough to fold and the second polymeric material providing a stiffness sufficient to properly hold the intraocular lens in place within a patient's eye.
The new intraocular lens of the present invention is a one-piece composite lens having a soft, foldable central optic region and a hard, non-foldable outer peripheral region making up the haptics or legs of the intraocular lens. The soft, central optic portion of the lens is typically manufactured from a material capable of being folded so that the intraocular lens can be inserted through a small ~0~~~~~
The invention provides a one-piece, small-incision intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion. This invention also provides a novel polymer composition for an intraocular lens utilizing two dissimilar polymeric materials to form a one-piece intraocular lens. This invention also provides a one-piece intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion while providing excellent biocompatibility with the patient's eye. Further, the invention provides a one-piece intraocular lens having a soft, foldable optic portion and a hard, stiff haptic portion wherein the stiff haptic portion has a further soft material at its terminus to protect the eye tissues at the point of contact without sacrificing the lens positioning properties of stiff haptics. This invention also provides a method of making a one-piece intraocular lens utilizing two dissimilar polymeric materials wherein one polymeric material is soft enough to fold and the second polymeric material providing a stiffness sufficient to properly hold the intraocular lens in place within a patient's eye.
The new intraocular lens of the present invention is a one-piece composite lens having a soft, foldable central optic region and a hard, non-foldable outer peripheral region making up the haptics or legs of the intraocular lens. The soft, central optic portion of the lens is typically manufactured from a material capable of being folded so that the intraocular lens can be inserted through a small ~0~~~~~
incision on the order of 3 to 4 mm. The hard haptic portion of the lens provides support for the lens in the eye after insertion and unfolding of the lens. The relatively rigid plastic lends support to the entire lens structure after its insertion into the posterior chamber of the eye, and tends to help stabilize the position of the lens after insertion and the closure of the incision.
The invention further describes a method of l0 strongly joining together two dissimilar polymer materials so that a one-piece faldable intraocular lens may be lathed from the composite material disc having two or more different polymer regions.
A preferred material of the soft optical region being a poly(hydroxyethyl methacrylate) or pHEMA
or a copolymer thereof such as HEMA and S-hydroxyhexyl methacrylate (HOHE7~iA) or p (HEPrIFr-co-HOHEXI~Ipr) . The preferred material of the hard haptic region being made from a relatively hard plastic, such as (polymethyl methacrylate) or Pl~r, or a copolymer thereof.
The method of the present invention comprises lathe-cutting discs from a rod into the intraocular lens of the present inventions. The discs can be made by a procedure which begins with pol~tnerizing in a tubular or cylindrical mold a liquid mixture of initia-for and monomer or comonomers such as HEI~3A ~r HEI~IA and HOHE7~IA or other acrylic monomers for forming an optically clear soft lens body. As is known in the art, it may be desirable to add a crosslinking matexial and ultraviolet absorbing compounds directly to this mixture prior to polymerization so as to be incorporat ed into the resultant polymer. The polymer rods produced by these means are then lathe cut, ar centerless ground, to the diameter of-the desired lens body.
2~~~~~~
The invention further describes a method of l0 strongly joining together two dissimilar polymer materials so that a one-piece faldable intraocular lens may be lathed from the composite material disc having two or more different polymer regions.
A preferred material of the soft optical region being a poly(hydroxyethyl methacrylate) or pHEMA
or a copolymer thereof such as HEMA and S-hydroxyhexyl methacrylate (HOHE7~iA) or p (HEPrIFr-co-HOHEXI~Ipr) . The preferred material of the hard haptic region being made from a relatively hard plastic, such as (polymethyl methacrylate) or Pl~r, or a copolymer thereof.
The method of the present invention comprises lathe-cutting discs from a rod into the intraocular lens of the present inventions. The discs can be made by a procedure which begins with pol~tnerizing in a tubular or cylindrical mold a liquid mixture of initia-for and monomer or comonomers such as HEI~3A ~r HEI~IA and HOHE7~IA or other acrylic monomers for forming an optically clear soft lens body. As is known in the art, it may be desirable to add a crosslinking matexial and ultraviolet absorbing compounds directly to this mixture prior to polymerization so as to be incorporat ed into the resultant polymer. The polymer rods produced by these means are then lathe cut, ar centerless ground, to the diameter of-the desired lens body.
2~~~~~~
This core rod is then centered in a larger diameter tubular mold and the polymerizable liquid that, upon curing, will comprise the hard, outer polymer segment is placed in contact with the rod.
In cases where the polymerizable outer liquid does not soften, or penetrate th~ core material (i.e., pFiEI~4A core with MMA sheath) , no bonding at the inter-face will take place. In these situations, bonding can be effected by pre-swelling the core material with a la solvent or swelling agent that is also miscible with the polymerizable outer liquid and can itself be polymerized: Alternatively, in some cases, the polymerizable swelling agent for the core polymer may be added directly to the polymerizable outer liquid.
~ third method to accomplish bonding is to alter the composition of the core rod so that the polymerizable outer liquid will than swell and pene-trots the core. This can be accomplished by adding a comonomer to the core monomer feed that will ultimately become the soft core rod, thus rendering the resultant copolymer more susceptible to swelling by the p~lymerizabl~ outer liquid that will ultimately become the hard, stiff outer sheath.
The resultant composite rod is then lathe cut ~5 on centerless ground to a diameter slightly larger than the length of the whole intraocular lens. The compos ite rod is then sawed or otherwise cut into discs of uniform thickness suitable for lathe cutting and machine milling in the conventional manner into an 30 intraocular lens of the preserxt invention having a soft, foldable optic portion and hard, stiff haptics for proper retenta.on in the eye.
p:n alternate embodiment of the invention provides a one-piece composite lens having a soft, 35 foldable central optic region and hard, non-foldable I
_ 7 _ outer haptic portion wherein the haptics have a further soft region at their outer terminus. The soft material region on the haptics is provided so as to cushion the point of contact between the patient's eye tissue and the haptic of the intraocular lens.
In one specific aspect, the invention provides a one-piece bicomposite intraocular lens capable of being inserted into an eye through an incision which is smaller than the diameter of the lens, comprising: a central, soft foldable optic portion of a high refractive index material capable of being folded by an ophthalmic surgeon during the process of inserting the lens during eye surgery; and a hard, stiff haptic portion of a relatively hard non-hydrogel plastic material formed about the outermost peripheral surface of said central optic portion for supporting said lens within the eye whereby said hard plastic material is joined to the periphery of the soft material by means of an interpenetrating polymer network to form a one-piece intraocular lens.
In another specific aspect, the invention provides a method for making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of: forming a core of a high refractive material suitable for use as an intraocular lens optic; swelling said core; polymerizing about said core a polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a composite rod; and machining said composite rod to form said composite intraocular lens having an optic portion and a haptic portion.
I i _ g _ In a further specific aspect, the invention provides a method fox making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of: forming a core of a high refractive material suitable for use as an intraocular lens optic, said high refractive material comprising a copolymer of hydroxyethyl methacrylate and a comonomer of hydroxyethyl methacrylate; swelling said core; positioning said core in a mold; placing a polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core; polymerizing said polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a one-piece rod; and machining said one-piece rod to form said composite intraocular lens having an optic portion and a haptic portion.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features, aspects, and advantages of the present invention will become more apparent when considered with respect to the following description, appended claims, and accompanying drawings, wherein:
Fig. 1 is a plan view of an exemplary composite intraocular lens including a central, soft, foldable optic portion and hard, stiff haptics provided in accordance with the practice of this invention;
Fig. 2 is a side view of the exemplary composite intraocular lens of Fig. 1;
Fig. 3 is a plan view of another embodiment of the invention illustrating a composite lens having a different i - 8a -configuration of soft and hard material portions of the lens; and Fig. 4 is a side view of the embodiment shown in Fig. 3.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figs. 1 and 2, an embodiment of an intraocular lens in accordance with the present invention is illustrated in a plan view (Fig. 1) and a side view (Fig.
2). Numeral 10 denotes the intraocular lens in general and 12 refers to the lens optic portion which is approximately 6 mm in diameter prior to hydration. The 6 mm diameter is fairly standard in the art, and is generally chosen to cover the pupil in its fully dilated state under naturally occurring conditions. However, other sizes are possible and this invention is in no way limited to any particular diameter or size. Furthermore, it is not necessary that the lens optic portion be circular; it could also be oval, square or any other shape as is desired.
The intraocular lens 10 comprises one or more non-optical haptic or leg components 14 extending away from the outermost peripheral surface of optic portion 12. The haptic components are useful for supporting the lens within the posterior chamber of the eye. Although the optic portion 12 of lens 10, shown in Fig. 2, is a bi-convex lens, (i.e., it has convex surfaces 16 and 18 on both its front and rear sides, respectively), lenses having any desired design configuration can be provided. Further, although two haptics 14 are shown, fewer or more haptics can be used as desired and the haptics can have configurations other than the configurations of the haptics shown in the various embodiments of the invention.
i I
- 8b -The intraocular lens of the present invention is a one-piece composite lens 10 having a soft foldable central optic portion 12 and stiffer, harder non-foldable haptic or leg components 14 extending outwardly from the outermost peripheral surface of optic portion 42. The lens of Fig. 1 may be folded prior to insertion by small, thin forceps of the type typically used by ophthalmic surgeons. Folding using the forceps occurs along center line 20 with the soft central portion 12 folding approximately in half to allow the lens to be inserted through a small incision of about 3 to 4 mm.
After the lens is in the targeted location, it is released to unfold. The material selected for central optic portion 12 is made of a physiologically inert soft polymeric material which is capable of providing a clear, transparent, refractive lens body even after folding and unfolding.
After the lens is unfolded, the forceps are extracted by the surgeon - g -through the incision and a positioning tool is used to properly locate the intraocular lens in the posterior chamber of the patient's eye.
The preferred material of the soft optic portion 12 being a poly(hydroxyethyl methacrylate) or pHEMA or a copolymer thereof such as HE~~l.A and 6-hydroxyhexyl methacrylate (HOHEXD~A) with polyfunctional crosslinking agents such as ethylene glycol dimethacrylate (EGDMA) or 1,6-hexanediol l0 dimethacrylate (HDDM). Other suitable materials for optic portion 12 are polymers of 2, 3-dihydroxypropyl methacrylate, and other hydrophilic amides and hydroxylated monomers and copolymers such as:
HEI~IA/N-vinylpyrrol idone 2,3-dihydroxypropyl methacrylate/methyl methacrylate HEMA/N-vinylpyrrolidone/methyl methacrylate HEMA/methacrylic acid HEMA/2-ethoxyethyl methacrylate HEI~IA/methacrylic acid/isobutyl methacrylate hydroxypropyl methacrylamide/methyl methacrylate HE1KA/n-butyl methacrylate HEMA/n-hexyl meth~crylate HE~2A/n-octyl methacrylate HEIdiA/hydroxyoctyl methacrylate , dimethyl acr~rlamide/diethyl acrylamide HEMA/n-hexyl acrylate HEMA/hydroxypropyl methacrylate Although acrylic hydrogels are the preferred materials for the foldable optic portion, the methods described herein can also b~ applied to loin hard polymers such as P1~MA to non-water-containing, soft polymers such as acrylic polymers and copolymers and silicones that have glass transition temperatures (Tg's) below physiologic temperatures.
~0~~3~~
-The terns '°soft" in the context of this application, is used to describe a polymeric material that has a Tg of less than 37oC when in the physiologic environment. Thus, pHEMA, which in its xerogel (dehy-5 drated) form has a high Tg (~ 100°C), is classified as a soft material because, after hydration, the Tg is <
37oC
Examples of non-water-containing, low Tg acrylic homopolymers are given below.
Tg~ C
poly (ethyl acrylate) -2~
poly (propyl acrylate) -~5 poly (n-butyl acrylate) -55 poly (is~btatyl acrylate) -43 poly (hexyl acrylate) -57 poly (2-ethylhexyl acrylate) -50 poly (2-ethoxyethyl acrylate) -50 poly (dodecyl acrylate) -30 poly (n-octyl ~nethacrylate) -2a poly (n-decyl methacrylate) -~0 poly (dodecyl methacrylate -65 Poly (tetradecyl methacrylate)-72 (hexadecyl methacrylate) -72 poly poly (octadecyl methacrylate) -100 It should be pointed out that the monomers used to prepare the above homopolymars can also be used 'to form copolymers monomers to form with other acrylic materials with intermediatevalues of Tg.
resultant We define the term purposes of this copolymer for the application to mean the polymer formed from 2 or more different polymsrizable monomers.
for a copo~.ymer The approximate value of T
g can be calculated from knowledge of the weight fraction (w) of each monomer T~ (oK) of each type and the homopolymer bys 1 _ y~71- + w2~ + . . i~dn~
T
Tg Tgl Tg2 gn ~~~~3:~0 The material of the hard, stiff haptic portions 1A being made from a relatively hand plastic such as poly(methyl methacrylate) or Pte, or a copolymer thereof.
The invention further describes a method of strangly joining together two dissimilar polymer materials such that a one-piece foldable intraocular lens may be machined from a camposite material disc.
These discs can be made by a procedure which begins with polymerizing in a tubular or cylindrical mold a liquid mixture of initiatar and monomer, comonomers or copolymer thereof as previously described for farming . an optically clear, soft, foldable lens optic portion 12.
It may be necessary to also add crosslinking agents such as ethylene glycol dimethacrylate (EGDMA), triethylene glycol dimethacrylate (TEGD1KA), or 1,6-hexanediol dimethacrylate (HDDM) or other bifunctional and polyfunctional monomers as is well known in the art in amounts in the range of 0-10~ to give the resultant copolymer dimensional stability. It may also be necessary to add ultraviolet (LTV) absorb~.ng compounds in with the lens body monomers prior to polymerization for incorporation into the resultant polymer as is well known in the art. The U~7 absorber should preferably be capable of polymerization into the lens matrix so as to resist extraction under physiolog-is conditions.
The polymer xods produced by ~thess means are then lathe cut to the prehydrated diameter or shape so as to obtain the desired lens opta.c portion 12. The resultant rods are then precisely mounted in the center of a cylindrical tubular mold and mixtures of initiator and monomers previously described as suitable for forming the polymer of the hard, stiff haptic material 2~a~~~(~
are added and polymerized to form a cylindrical ring around the rod of the polymer used to form the lens optic portion 12. However, it is also possible to mount the polymer rods of the lens optic poxtion 12 off center such than an intraocular lens of a different shape or configuration may be obtained such ~s an oval or sc~uaxe optic portion or the like.
It may also be desirable to provide a physic-logical dye into the surbounding ring mixture so that the haptics 14 will be colored to allow the intraocular lens to be easily seen once placed into the patient's eye by the surgeon. Color can bs imparted by incorpo-rating into the surrounding ring mixture, any physiolog-ically compatible dye such as D & C Green #6, which, despite its name, provides a blue color into the haptic portion of the intraocular lens:
It may be necessary to place a solvent or swelling agent in contact with the material of the central optic portion (e. g. pHEMA rod) before polymer-izing the surrounding cylindrical PP~MA ring portion to the rod so that a good bond therebetwsen will be obtained. This can be accomplished by using a swelling agent which will be miscible with both the material of the cylindrical ring portion and the core material and is itself polymsrizabl~. The rod can be immersed into the solvent or swelling agent for a predetermined period of time and then remaved and rinsed before being polymerized to the material of the surrounding ring portion or the swelling agent can bs mixed in the material of the surrounding ring portion and b~ cured to the rod in con~unation with the material of the cylindrical ring portion.
As discussed above, the preferred material of the central optic portion is an acrylic hydrogel pHEI~A
or a copAlymer thereof. The preferred polymerizable i solvent or swelling agent miscible with the pHEMA is HEMA in most of the examples. The material of the surrounding cylindrical ring portion is Pl~iA, such that the HEMA (swelling agent) is miscible with the 1~IA
monomer.
An explanation of how this provides a good bond, or adhesion, between the two dissimilar polymer layers is that the pHEMA or pHEMA copolymer rod core portion is swelled on its surface by the HEMA solvent 1p or swelling agent. The 1~IA monomer of the cylindrical ring portion can then diffuse into this softened layer because the HEMA and I~IA are miscible and, upon poly-merization of the NB~iA, an interpenetrating polymer network forms at the interface. This interlocked network of pHEMA and PIMA chains provide a good strong mechanical bond between the two materials, even after the pHEMA portion is hydrated.
The resultant 'composite material rod is then lathe cut or ground to a radius 1.0-3.0 mm more than the distance from the center of the lens body to the furthest edge of the legs. This rod is then sawed or otherwise cut into discs of uniform thickness suitable for lathe cutting and machine milling in the conven-tional manner into the intraocular lens of the present invention. .
A second embodiment of the invention is shown in Fig. 3 and 4 wherein an intraocular lens 40 is illustrated. The lens 40 includes a soft, foldable optic portion 42 and.. stiffer, harder non-foldable haptic or leg portions 44 extending outwardly from the outermost peripheral surface of optic portion 42.
Each leg 44 includes a region near its outer end which contacts the eye tissue designated as 46. It is desirable that regions 46 of the. leg portions 44 be manufactured out of a soft, compressible material which will not harm the delicate ~~?~~3~0 _14_ eye tissue which it will contact when positioned within a patient's eye.
A satisfactory material for use in regions 46 of haptics 44 is the pHEMA or copolymer thereof used for the central optic portion as previously described.
To form an integral intraocular lens having a soft, foldable central optic portion and hard, stiff haptic regions including compressible zones 46 on haptics 44, the Lens body or optic portion and cylindrical ring ZO portion are polymerized in a tube by the methods described above and then lathe cut to a radius 0.1-1.0 mm less than the distance from the center of the lens body to the interface between the compressible material 46 and the eye tissue which the compressible material will contact. Tha resultant rods are then precisely mounted in the canter of a second cylindrical tubular mold and mixtures of initiator and monomers, previously described as suitable for forming the polymer of the compressible material 46, are added and polymerized to 2.0 form a second cylindrical ring around the central rod and first cylindrical ring used to form the lens body and mast or all of the legs of the lens. The resultant rod is then lathe cut to a radius 1.0-3.0 mm more than the distance from the center of the lens body to the farthest edge of the legs. This rod is then sawed or otherwise cut into discs of uniform thickness, suitable for lathe cutting and machine milling in the conven-tional manner into the intraocular lens of the present invention, as previously described.
It is felt that the invention is best de-scribed by reference to the following examples which illustrate the various methods of manufacturing an exemplified intraocular lens. The following examples are representative of Laboratory results demonstrating both unsuccessful and successful formation of composite ii ~
intraocular lenses from two dissimilar materials as described above.
EXAMPLE I
Three pHEMA rods approximately 2.5 inches long by 0.4 inches in diameter, crosslinked with 1% by weight ethylene glycol dimethacrylate (EGDMA), and three pHEMA rods crosslinked with 4% by weight triethylene glycol dimethacrylate (TEGDMA) of similar l0 size were centered by means of TeflonT'"spacers inside polypropylene test tubes (approximately 3.5 inches long by 0.75 inches inside diameter).- To each mold was added a solution of methyl methacrylate (MMA, 100 parts by weight), EGDMA (1.0 parts by weight), 2,2-azobisisobutyronitrile (AIBN, 0.0875 parts by weight), and D & C Green No. 6 (0.10 parts by weight).
The molds were stoppered shut with flanged Teflon plugs having a Viton~""O-ring around the circumference of the plug to provide a good seal. The tubes were suspended in a water bath held at 40°C for 47 hours and the bath was subsequently ramped to 60°C for 20 hours, removed from the bath, and further cured in a forced-air oven at 100°C for 20 hours. This is referred to as the standard cure method. After cooling, the cured rods were removed from the molds and sliced into discs (1 mm to 3 mm in thickness). The incorporation of the blue dye, (D & C Green No. 6) in the sheath or surrounding cylindrical ring solution, allowed for easy inspection of the core/sheath or central optic portion/haptic portion interface. In this and all examples, no blue dye was seen to penetrate into the pHEMA core. Fur-thermore, the colorless core could be readily pushed out of the composite disc indicating that the liquid MMA did not penetrate or diffuse into the pHEMA core to any significant extent prior to polymerizing.
~0~$3~~
Therefore, a composite intraocular lens manufactured according to this example would not exemplify the teachings of the present invention because the part of the lens comprising the sheath material (the legs or haptics 14 and 44 of Figs. 1 and 3, respectively) would easily fall off or break away from the central optic region of the lens.
Exarspz.E Iz The experiment described in Example I was repeated using two core rods of pHEMA and two core rods of a copolymer of HEIR and 1~IA, or p (HEidA-co-I~'IA) , at a 50/50 mol ratio and two core rods of a copolymer p (HET~A-co-Ice) at a 75/25 mol ratio of HEMA to i~iA.. No crosslinker was present iri any of the core rods of this example. These rods were centered in a mold as de-scribed in Example I, and to each mold was added a solution of (100 parts by weight), EGD1KA (1.0 parts), AzBN (0.05 parts), ana D & ~ Green No. 6 (0.10 parts). The rods were cured using the standard cure method as in Example T. The colorless center Gore could be pushed out oø the composite disc in the case of the pHEr~/r~ and 7525 p (HEM-c~-) /rte composite discs, but not in the case of the discs sliced from the 50/50 p(HEIyIA°co-I~IA)/MMA composite rods. However, after these lathed discs were hydrated in water, the center core portion could ba easily pushed out or eliminated from the sheath portion. Therefore, a composite intraocular lens manufactured according to this example would not perform in accordance with the teachings of the present invention.
EXI~klPLE TII
The experiment described in Example I was repeated using both pHEMA and ?5/25 p (HE2~-co-MP3A) ~~~~3~~
- l~ -central core rods containing no crosslinker. In this example, the sheath casting solutions that were placed in the molds surrounding the core rods were solutions of MMA and HEMA at 90/10 and 80/20 mol ratios of MMA to HEMA (no added crosslinker). The composite rods were cured in the standard cure method of Example I. The cured rods were sliced into discs and, from the discs, intraocular lens were made using standard lathing and milling techniques having a central soft optic portion and harder, stiffer blue haptic portions. The lenses were hydrated in distilled water and the blue haptics were found to be securely joined to the clear optic portion of the lens in the case of the 75/25 p(HEMA-co-MMA) core rods, but not in the case of the pHEMA core rods.
EXAMPLE IV
Core rods (0.40 inch diameter) made from the pHEMA of Examples I and II, crosslinked with l mol percent TEGDMA, were immersed in distilled HEMA at room temperature and the average increase in diameter of the rods was measured with calipers at various intervals as shown in Table I below.
TABLE Z
Immersion Time Diameter Increase (in days) (inches) 1 0.003 2 0.005 22 0.010 The 22-day-swelled rods were subsequently made into composite rods with a PMMA sheath including an EGDMA
(1.0 park) crosslinker, AIBId (9.05 parts) initiator, and D & C Green No. 6 dye (0.10 parts). The cured rods were sliced into discs and hydrated as described previously. The blue PMMA haptic portion was faund to adhere strongly to the colorless pHEMA central optic portion .as determined by pull tests. No failures occurred at the pHEMA/PMMA interface.
EXAMPLE V
This experiment was conducted to determine the effect of pore surface area on adherence of the sheath polymeric material. Copolymer core rods, made l0 from a 70/30 mol ratio of HEMA and 6-hydroxyhexyl methacrylate (HOHEXMA) or p(HEMA-co-HOHEXMA) and crosslinked with 3 mol percent of triethylene glycol dimethacrylate (TE~DMA) plus 1,6-hexanediol dimethacrylate, were turned on a lathe to a diameter of 0.375 inches. One of the lathed cores was allowed to swell in water overnight and was subsequently freeze-dried. A second lathed core was wiped with an acetone-damp cloth prior to being centered in the mold.
A third core was used as cash (not lathed). MMA (100 parts by weight) containing EGDMA (1.0 part), AIBN
(0.05 parts) , and D & C Green Na. 6 (0.10 parts) were cast around each core as in Example I. The aura conditions were similar to those of Example I: The cured rods were sliced into discs 1-3 mm thick and imanersed in water to test the integrity of the inter_ face. The two polymeric zones ware strongly bonded together in all three cases.
EPLE VI
Three 70/30 mol ratio p(HEMA-co-HOHEXMA) core rods that had been prwiously lathed to 0.375 inch diameter were allowed to soak in distilled HEMA far 22 hours at room temperature. The excess HEMA was blotted off and the cores were centered in polypropylene test tubes using polypropylene spacegs as described in 1g -Example T. A solution of MMA (100 parts by weight), EG~rla ( 1 part) , Alan ( o . 05 parts ) , ana n & c green r~o .
6 (0.10 parts) was poured around the cores and the sealed molds were cured in a similar fashion to Example 1. The cured rods were turned down on a lathe to 16.4 mm diameter and sliced into 3 mm thick discs. The discs were checked for concentricity and those discs having a clear, central optic portion perfectly cen-tered in the composite disc were made into one-piece l0 composite intraocular lenses of a design similar to Figs. 1 and 2. In hydrated form, the lenses could be folded repeatedly without damaging the clear, foldable optic portion or the colored, non-foldable haptic portions of the lens. Pull or tensile tests (discussed below) established that the PMMA haptic region was strangly affixed to the hydrogel core.
EXAMPLE VII
Example VT was repeated, however, in this example the 70/30 mol ratio p(HEMA-co-HOHEXMA) core rods were allowed to soak in distilled HEMA for 48 hours at room temperature prior to casting in the MMA
solution of Example V: The rods were cured in both the standard way as shown in Example I and in an accelerat ed manner wherein the tubes were suspended in a water bath being tamped from 41°C to 61°C for 3 hours and then held at 61o far 24 hours. The tubes were removed from the bath and further cured in a forced-air oven at 113oc for 38 hours. One Core rod Was cast into .a composite using a sheath solution of MMA/HEMA (l00 parts by weight, g5/5 mol ratio), EGDMA (1 part), AI~PI
(0.05 parts) and n & C Green No. 6 (0.10 parts) under the accelerated cure condition discussed above. The cured rods were machined into one-piece intraocular lenses as shown in Figs. 1 and 2 and, subsequently, i I
hydrated. No qualitative differences could be seen in the strength of the interface between the rods cured under the standard or accelerated conditions in the cases wherein the sheath solution was the I~IA solution 5 of Example V. However, failure at the interface was noted in blanks cut from the rod wherein the sheath solution was the 95/5 mol ratio MrIA/HEMA.
]F~X~M~LE VIII
Y
Three 70/30 mot ratio p(HEMA-co-HOHEXMA) core rods were lathed to 0.236 inch diameter (6.0 mm).
These rods were not preswelled. -The rods were centered in PyreX molds. A sheath solution of 100 parts l~iA, ' 1.0 parts EGDMA, 0.05 parts AIBN, and 0.10 parts D & C
15 Green No. 6 was poured into the mold which was then sealed as discussed above. The rods were cured in accordance with this accelerated method as described in Example VI. The cured rods were sliced into lens blanks. Composite intraocular lenses having a 6 mm 20 diameter central optic portion were fashioned from the lens blanks as is well known in the art. The lenses were hydrated and the strength of the hydrogel/PMMA
interface was found to be strong.
Table 2 below depicts the results of Examples I through VIII:
2Q~83~
,ga W N F-' O
0 0~ o~
J~: Jr. V ~l~'. w)~ J~.171~.
1 v v s ~~O~O~ ~ W ~ ~ ..~. .Or ~L'f' ,~,, v ~':v~
z x N N z z z z z ~'1 ° ~1 ° N
~~~~
m @~ nn ~
~ co m .-...: ..:,.
W W
N N !-' 1-' O O O O
vv vv ~ 22 ~~~$36~G
w ~ cu s~ n ax w a, N -~ ~ ~ O
O h' tOJI W WN
Ov In d K ~c o' N
~b ob ab n~u ~b ~ ;° o ... .~ ....
''f~' N
2~~~3~a EXAMPLE TX
TENSILE TEST
Copolymer core rods were prepared from 5 different mol ratios of HEMA to HOHEXMA; 70/30, 75/25, 80/20, 85/15, and 90/10, each having 3 mol percent of hexanediol dimethacrylate (HDDM) crosslinker. Three methods of forming the composite rods were utilized for this Example (A, H and C).
Method A utilized cores which were 6.0 mm (0.236 inches) in diameter. The cores were preswelled for 24 hours in HEMA. The tubes were suspended in a water bath ranging from 40 to 60oC for 3 hours, held at 60oC for 26.5 hours, removed from the bath, and further cured in a forced-air aven at 110oC far 42 hours.
Method H utilized core rods of the 5 differ-ent mol ratios by allowing the cores to stand at 40°C
for 21 hours, prior to affecting cure by ramping the temperature to 60°C. This is equivalent to the stan-dard cure conditions specified in Examples I-III and VI.
Method C utilized core rods prepared by the accelerated pure conditions as shown in Example VIII.
In all threw methods, the sheathing material is PMMA
formulated as disclosed in the previous examples.
All samples were milled into rectangular slivers approximately 0:17 to 0.18 mm square, and 12 mm in length. Each sliver contained a blue (PMMfA) and clear (hydrogel) region of unequal area. Hoth hydrated (distilled water) (Table 3) and nonhydr~ted (Table 4) specimens wars pulled apart using a pull tester and both the forge at break and the lacation of the break was noted.
The tensile strengths were determined by dividing the force at the break by~ the cross-sectional urea. The break locations were divided into four regions the blue PMt~IA region, the clear hydrogel 2~~~~ ~~' _ 24 °
region, the interfacial region (fragments contain both colors), and the interfacial line (all blue and all clear fragments).
!I 3 PITS TEST RESULTS ° SITE ~Ah Hydrated in distilled water to ~_____ I I I
I~ATZ~1 I
I T~1SILE I I
'p4~) I I I I ~ Iii .
p~ ~TZas I r~~oy t) I ~ I zna~ ~iort I ~~or~ I
70/30 A 1.4 5o. a% 20.0% 20.0% lo.
o%
75/25 A 1.6 9.0% 55.0% 9.0% 27.0%
80/20 A 1.4 18.2% 27.3% 9.0% 45.5%
85/15 A 1.7 10.0% 50.0% 10.0% 30.0%
90/10 A 1.5 20.0% 40.0% 7Ø0% 30.0%
70/30 B 1.3 22.0% 78.0% -_ ""
75/25 H 1.4 - 45.4% 27.3% 27.3%
80/20 H 1.4 18.2% 27.3% 36.3% 18.2%
85/1,5 H 1.5 30.0% 10.0% 20.0% 40,0%
90/10 B 1.5 22.0% 78.0% _ -2 70/30 C 1.5 43.0% -- 14.0% 43.0%
75/25 C 1.9 -- 60.0% 10.0% 30.0%
80/20 C 1.3 12.5% 50.0% 12.5% 25.0%
85/15 C 1.2 31.0% 15.0% 31.0% 23.0%
90/10 C 1.4 20.0% 40.0% 20.0% 20.0%
20~~3~,0 _ 25 _ TA'8L~ 4 ~ TEST - TTE MATERIAL
Nonhydrated -.-- ___..
C~FtE j j ( ( I SOZI~OId I . I ( ELK I~ATIOrI ( I ~ (-~- I I Ti~sz~ j I
~ I $I I nrr~I xx~cy ir~L gas I May ~2) I ~z~ I LINE ~r pcioN I
70/30 .~ 9.3 27.3% 9.0% 27.3% 36.4%
75/25 .A 9.1 60:0% - 10.4% 30.0%
2 0 80/20 A 7.9 50. 0% -'-- 10. 0% 40. 0% , 85/15 A: 9.5 67. Q% ~-- - 33.0%
90/10 A 8:9 33.3% 22.2% 44:5%
70/30 E 9.3 50.0% w-- -- 50.0%
75/25 B 8.4 45.4% --- 36.3% 18.2%
8Q/20 B 7.3 80.0% --- 10.0% 10: Q%
85/15 B 8.9 67.0$ -- 33.0%
90/10 B 8.8 62.5% 12.5% 12.5% 12:5%
70/30 C 9.2 57.0% --- -- 43.0%
75/25 C 9.6 67.0% --- 11.0% 22.0%
3 0 80/20 C 7. 3 37 . 5% 37 . 25 0 0%
5%
85/15 C 7.1 6?:0% - 31:0% 23.0%
90/10 C g.0 56:0% '-" 8.0% 25.0%
- 2s _ In the nonhydrated condition (Table 4), the tensile strength values are consistent with those expected for pure PT~lA or nonhydrated hydrogel. Only a small percentage of the breaks occurred at the interfacial line, indicating that the adhesion of the two materials is excellent.
The tensile strength values of the hydrated slivers are much lower which .is not unexpected as the . tensile strength of the hydrogel portions should decrease with increasing water content. However, no obvious decrease in tensile strength is seen between the various, p(HEP3~r-co~HOHE7~tA) mot ratios. As can be seen in Table 3, a greater percentage of failures occur at the interfacial line as compared to the dry speci-mans. This might be the penult of stress brought about by the proximity of regions of vastly different aqueous expansion coefficient. However, the average tensile strength at break was not found to be significantly lower in specimens that broke'at the interface line.
I~ should also be ruled that no mayor differ-ences in tensile strength or in the location of break were noted between Method A, B or C of composite curing methods. Therefore, all 3 methods represent viable ways to prepare the composite intraacular lenses.
The embodiments above are intended to be illustrative of the invention, and it is expected, that those of ordinary skill in the art may, in view of the teachings contained hereinabove, be able to modify the embodiments illustrated herein. It is intended to lower all such modifications which fell ~withir~ the spirit and scope of the Invention as defined by the claims appended hereto.
In cases where the polymerizable outer liquid does not soften, or penetrate th~ core material (i.e., pFiEI~4A core with MMA sheath) , no bonding at the inter-face will take place. In these situations, bonding can be effected by pre-swelling the core material with a la solvent or swelling agent that is also miscible with the polymerizable outer liquid and can itself be polymerized: Alternatively, in some cases, the polymerizable swelling agent for the core polymer may be added directly to the polymerizable outer liquid.
~ third method to accomplish bonding is to alter the composition of the core rod so that the polymerizable outer liquid will than swell and pene-trots the core. This can be accomplished by adding a comonomer to the core monomer feed that will ultimately become the soft core rod, thus rendering the resultant copolymer more susceptible to swelling by the p~lymerizabl~ outer liquid that will ultimately become the hard, stiff outer sheath.
The resultant composite rod is then lathe cut ~5 on centerless ground to a diameter slightly larger than the length of the whole intraocular lens. The compos ite rod is then sawed or otherwise cut into discs of uniform thickness suitable for lathe cutting and machine milling in the conventional manner into an 30 intraocular lens of the preserxt invention having a soft, foldable optic portion and hard, stiff haptics for proper retenta.on in the eye.
p:n alternate embodiment of the invention provides a one-piece composite lens having a soft, 35 foldable central optic region and hard, non-foldable I
_ 7 _ outer haptic portion wherein the haptics have a further soft region at their outer terminus. The soft material region on the haptics is provided so as to cushion the point of contact between the patient's eye tissue and the haptic of the intraocular lens.
In one specific aspect, the invention provides a one-piece bicomposite intraocular lens capable of being inserted into an eye through an incision which is smaller than the diameter of the lens, comprising: a central, soft foldable optic portion of a high refractive index material capable of being folded by an ophthalmic surgeon during the process of inserting the lens during eye surgery; and a hard, stiff haptic portion of a relatively hard non-hydrogel plastic material formed about the outermost peripheral surface of said central optic portion for supporting said lens within the eye whereby said hard plastic material is joined to the periphery of the soft material by means of an interpenetrating polymer network to form a one-piece intraocular lens.
In another specific aspect, the invention provides a method for making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of: forming a core of a high refractive material suitable for use as an intraocular lens optic; swelling said core; polymerizing about said core a polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a composite rod; and machining said composite rod to form said composite intraocular lens having an optic portion and a haptic portion.
I i _ g _ In a further specific aspect, the invention provides a method fox making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of: forming a core of a high refractive material suitable for use as an intraocular lens optic, said high refractive material comprising a copolymer of hydroxyethyl methacrylate and a comonomer of hydroxyethyl methacrylate; swelling said core; positioning said core in a mold; placing a polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core; polymerizing said polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a one-piece rod; and machining said one-piece rod to form said composite intraocular lens having an optic portion and a haptic portion.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features, aspects, and advantages of the present invention will become more apparent when considered with respect to the following description, appended claims, and accompanying drawings, wherein:
Fig. 1 is a plan view of an exemplary composite intraocular lens including a central, soft, foldable optic portion and hard, stiff haptics provided in accordance with the practice of this invention;
Fig. 2 is a side view of the exemplary composite intraocular lens of Fig. 1;
Fig. 3 is a plan view of another embodiment of the invention illustrating a composite lens having a different i - 8a -configuration of soft and hard material portions of the lens; and Fig. 4 is a side view of the embodiment shown in Fig. 3.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figs. 1 and 2, an embodiment of an intraocular lens in accordance with the present invention is illustrated in a plan view (Fig. 1) and a side view (Fig.
2). Numeral 10 denotes the intraocular lens in general and 12 refers to the lens optic portion which is approximately 6 mm in diameter prior to hydration. The 6 mm diameter is fairly standard in the art, and is generally chosen to cover the pupil in its fully dilated state under naturally occurring conditions. However, other sizes are possible and this invention is in no way limited to any particular diameter or size. Furthermore, it is not necessary that the lens optic portion be circular; it could also be oval, square or any other shape as is desired.
The intraocular lens 10 comprises one or more non-optical haptic or leg components 14 extending away from the outermost peripheral surface of optic portion 12. The haptic components are useful for supporting the lens within the posterior chamber of the eye. Although the optic portion 12 of lens 10, shown in Fig. 2, is a bi-convex lens, (i.e., it has convex surfaces 16 and 18 on both its front and rear sides, respectively), lenses having any desired design configuration can be provided. Further, although two haptics 14 are shown, fewer or more haptics can be used as desired and the haptics can have configurations other than the configurations of the haptics shown in the various embodiments of the invention.
i I
- 8b -The intraocular lens of the present invention is a one-piece composite lens 10 having a soft foldable central optic portion 12 and stiffer, harder non-foldable haptic or leg components 14 extending outwardly from the outermost peripheral surface of optic portion 42. The lens of Fig. 1 may be folded prior to insertion by small, thin forceps of the type typically used by ophthalmic surgeons. Folding using the forceps occurs along center line 20 with the soft central portion 12 folding approximately in half to allow the lens to be inserted through a small incision of about 3 to 4 mm.
After the lens is in the targeted location, it is released to unfold. The material selected for central optic portion 12 is made of a physiologically inert soft polymeric material which is capable of providing a clear, transparent, refractive lens body even after folding and unfolding.
After the lens is unfolded, the forceps are extracted by the surgeon - g -through the incision and a positioning tool is used to properly locate the intraocular lens in the posterior chamber of the patient's eye.
The preferred material of the soft optic portion 12 being a poly(hydroxyethyl methacrylate) or pHEMA or a copolymer thereof such as HE~~l.A and 6-hydroxyhexyl methacrylate (HOHEXD~A) with polyfunctional crosslinking agents such as ethylene glycol dimethacrylate (EGDMA) or 1,6-hexanediol l0 dimethacrylate (HDDM). Other suitable materials for optic portion 12 are polymers of 2, 3-dihydroxypropyl methacrylate, and other hydrophilic amides and hydroxylated monomers and copolymers such as:
HEI~IA/N-vinylpyrrol idone 2,3-dihydroxypropyl methacrylate/methyl methacrylate HEMA/N-vinylpyrrolidone/methyl methacrylate HEMA/methacrylic acid HEMA/2-ethoxyethyl methacrylate HEI~IA/methacrylic acid/isobutyl methacrylate hydroxypropyl methacrylamide/methyl methacrylate HE1KA/n-butyl methacrylate HEMA/n-hexyl meth~crylate HE~2A/n-octyl methacrylate HEIdiA/hydroxyoctyl methacrylate , dimethyl acr~rlamide/diethyl acrylamide HEMA/n-hexyl acrylate HEMA/hydroxypropyl methacrylate Although acrylic hydrogels are the preferred materials for the foldable optic portion, the methods described herein can also b~ applied to loin hard polymers such as P1~MA to non-water-containing, soft polymers such as acrylic polymers and copolymers and silicones that have glass transition temperatures (Tg's) below physiologic temperatures.
~0~~3~~
-The terns '°soft" in the context of this application, is used to describe a polymeric material that has a Tg of less than 37oC when in the physiologic environment. Thus, pHEMA, which in its xerogel (dehy-5 drated) form has a high Tg (~ 100°C), is classified as a soft material because, after hydration, the Tg is <
37oC
Examples of non-water-containing, low Tg acrylic homopolymers are given below.
Tg~ C
poly (ethyl acrylate) -2~
poly (propyl acrylate) -~5 poly (n-butyl acrylate) -55 poly (is~btatyl acrylate) -43 poly (hexyl acrylate) -57 poly (2-ethylhexyl acrylate) -50 poly (2-ethoxyethyl acrylate) -50 poly (dodecyl acrylate) -30 poly (n-octyl ~nethacrylate) -2a poly (n-decyl methacrylate) -~0 poly (dodecyl methacrylate -65 Poly (tetradecyl methacrylate)-72 (hexadecyl methacrylate) -72 poly poly (octadecyl methacrylate) -100 It should be pointed out that the monomers used to prepare the above homopolymars can also be used 'to form copolymers monomers to form with other acrylic materials with intermediatevalues of Tg.
resultant We define the term purposes of this copolymer for the application to mean the polymer formed from 2 or more different polymsrizable monomers.
for a copo~.ymer The approximate value of T
g can be calculated from knowledge of the weight fraction (w) of each monomer T~ (oK) of each type and the homopolymer bys 1 _ y~71- + w2~ + . . i~dn~
T
Tg Tgl Tg2 gn ~~~~3:~0 The material of the hard, stiff haptic portions 1A being made from a relatively hand plastic such as poly(methyl methacrylate) or Pte, or a copolymer thereof.
The invention further describes a method of strangly joining together two dissimilar polymer materials such that a one-piece foldable intraocular lens may be machined from a camposite material disc.
These discs can be made by a procedure which begins with polymerizing in a tubular or cylindrical mold a liquid mixture of initiatar and monomer, comonomers or copolymer thereof as previously described for farming . an optically clear, soft, foldable lens optic portion 12.
It may be necessary to also add crosslinking agents such as ethylene glycol dimethacrylate (EGDMA), triethylene glycol dimethacrylate (TEGD1KA), or 1,6-hexanediol dimethacrylate (HDDM) or other bifunctional and polyfunctional monomers as is well known in the art in amounts in the range of 0-10~ to give the resultant copolymer dimensional stability. It may also be necessary to add ultraviolet (LTV) absorb~.ng compounds in with the lens body monomers prior to polymerization for incorporation into the resultant polymer as is well known in the art. The U~7 absorber should preferably be capable of polymerization into the lens matrix so as to resist extraction under physiolog-is conditions.
The polymer xods produced by ~thess means are then lathe cut to the prehydrated diameter or shape so as to obtain the desired lens opta.c portion 12. The resultant rods are then precisely mounted in the center of a cylindrical tubular mold and mixtures of initiator and monomers previously described as suitable for forming the polymer of the hard, stiff haptic material 2~a~~~(~
are added and polymerized to form a cylindrical ring around the rod of the polymer used to form the lens optic portion 12. However, it is also possible to mount the polymer rods of the lens optic poxtion 12 off center such than an intraocular lens of a different shape or configuration may be obtained such ~s an oval or sc~uaxe optic portion or the like.
It may also be desirable to provide a physic-logical dye into the surbounding ring mixture so that the haptics 14 will be colored to allow the intraocular lens to be easily seen once placed into the patient's eye by the surgeon. Color can bs imparted by incorpo-rating into the surrounding ring mixture, any physiolog-ically compatible dye such as D & C Green #6, which, despite its name, provides a blue color into the haptic portion of the intraocular lens:
It may be necessary to place a solvent or swelling agent in contact with the material of the central optic portion (e. g. pHEMA rod) before polymer-izing the surrounding cylindrical PP~MA ring portion to the rod so that a good bond therebetwsen will be obtained. This can be accomplished by using a swelling agent which will be miscible with both the material of the cylindrical ring portion and the core material and is itself polymsrizabl~. The rod can be immersed into the solvent or swelling agent for a predetermined period of time and then remaved and rinsed before being polymerized to the material of the surrounding ring portion or the swelling agent can bs mixed in the material of the surrounding ring portion and b~ cured to the rod in con~unation with the material of the cylindrical ring portion.
As discussed above, the preferred material of the central optic portion is an acrylic hydrogel pHEI~A
or a copAlymer thereof. The preferred polymerizable i solvent or swelling agent miscible with the pHEMA is HEMA in most of the examples. The material of the surrounding cylindrical ring portion is Pl~iA, such that the HEMA (swelling agent) is miscible with the 1~IA
monomer.
An explanation of how this provides a good bond, or adhesion, between the two dissimilar polymer layers is that the pHEMA or pHEMA copolymer rod core portion is swelled on its surface by the HEMA solvent 1p or swelling agent. The 1~IA monomer of the cylindrical ring portion can then diffuse into this softened layer because the HEMA and I~IA are miscible and, upon poly-merization of the NB~iA, an interpenetrating polymer network forms at the interface. This interlocked network of pHEMA and PIMA chains provide a good strong mechanical bond between the two materials, even after the pHEMA portion is hydrated.
The resultant 'composite material rod is then lathe cut or ground to a radius 1.0-3.0 mm more than the distance from the center of the lens body to the furthest edge of the legs. This rod is then sawed or otherwise cut into discs of uniform thickness suitable for lathe cutting and machine milling in the conven-tional manner into the intraocular lens of the present invention. .
A second embodiment of the invention is shown in Fig. 3 and 4 wherein an intraocular lens 40 is illustrated. The lens 40 includes a soft, foldable optic portion 42 and.. stiffer, harder non-foldable haptic or leg portions 44 extending outwardly from the outermost peripheral surface of optic portion 42.
Each leg 44 includes a region near its outer end which contacts the eye tissue designated as 46. It is desirable that regions 46 of the. leg portions 44 be manufactured out of a soft, compressible material which will not harm the delicate ~~?~~3~0 _14_ eye tissue which it will contact when positioned within a patient's eye.
A satisfactory material for use in regions 46 of haptics 44 is the pHEMA or copolymer thereof used for the central optic portion as previously described.
To form an integral intraocular lens having a soft, foldable central optic portion and hard, stiff haptic regions including compressible zones 46 on haptics 44, the Lens body or optic portion and cylindrical ring ZO portion are polymerized in a tube by the methods described above and then lathe cut to a radius 0.1-1.0 mm less than the distance from the center of the lens body to the interface between the compressible material 46 and the eye tissue which the compressible material will contact. Tha resultant rods are then precisely mounted in the canter of a second cylindrical tubular mold and mixtures of initiator and monomers, previously described as suitable for forming the polymer of the compressible material 46, are added and polymerized to 2.0 form a second cylindrical ring around the central rod and first cylindrical ring used to form the lens body and mast or all of the legs of the lens. The resultant rod is then lathe cut to a radius 1.0-3.0 mm more than the distance from the center of the lens body to the farthest edge of the legs. This rod is then sawed or otherwise cut into discs of uniform thickness, suitable for lathe cutting and machine milling in the conven-tional manner into the intraocular lens of the present invention, as previously described.
It is felt that the invention is best de-scribed by reference to the following examples which illustrate the various methods of manufacturing an exemplified intraocular lens. The following examples are representative of Laboratory results demonstrating both unsuccessful and successful formation of composite ii ~
intraocular lenses from two dissimilar materials as described above.
EXAMPLE I
Three pHEMA rods approximately 2.5 inches long by 0.4 inches in diameter, crosslinked with 1% by weight ethylene glycol dimethacrylate (EGDMA), and three pHEMA rods crosslinked with 4% by weight triethylene glycol dimethacrylate (TEGDMA) of similar l0 size were centered by means of TeflonT'"spacers inside polypropylene test tubes (approximately 3.5 inches long by 0.75 inches inside diameter).- To each mold was added a solution of methyl methacrylate (MMA, 100 parts by weight), EGDMA (1.0 parts by weight), 2,2-azobisisobutyronitrile (AIBN, 0.0875 parts by weight), and D & C Green No. 6 (0.10 parts by weight).
The molds were stoppered shut with flanged Teflon plugs having a Viton~""O-ring around the circumference of the plug to provide a good seal. The tubes were suspended in a water bath held at 40°C for 47 hours and the bath was subsequently ramped to 60°C for 20 hours, removed from the bath, and further cured in a forced-air oven at 100°C for 20 hours. This is referred to as the standard cure method. After cooling, the cured rods were removed from the molds and sliced into discs (1 mm to 3 mm in thickness). The incorporation of the blue dye, (D & C Green No. 6) in the sheath or surrounding cylindrical ring solution, allowed for easy inspection of the core/sheath or central optic portion/haptic portion interface. In this and all examples, no blue dye was seen to penetrate into the pHEMA core. Fur-thermore, the colorless core could be readily pushed out of the composite disc indicating that the liquid MMA did not penetrate or diffuse into the pHEMA core to any significant extent prior to polymerizing.
~0~$3~~
Therefore, a composite intraocular lens manufactured according to this example would not exemplify the teachings of the present invention because the part of the lens comprising the sheath material (the legs or haptics 14 and 44 of Figs. 1 and 3, respectively) would easily fall off or break away from the central optic region of the lens.
Exarspz.E Iz The experiment described in Example I was repeated using two core rods of pHEMA and two core rods of a copolymer of HEIR and 1~IA, or p (HEidA-co-I~'IA) , at a 50/50 mol ratio and two core rods of a copolymer p (HET~A-co-Ice) at a 75/25 mol ratio of HEMA to i~iA.. No crosslinker was present iri any of the core rods of this example. These rods were centered in a mold as de-scribed in Example I, and to each mold was added a solution of (100 parts by weight), EGD1KA (1.0 parts), AzBN (0.05 parts), ana D & ~ Green No. 6 (0.10 parts). The rods were cured using the standard cure method as in Example T. The colorless center Gore could be pushed out oø the composite disc in the case of the pHEr~/r~ and 7525 p (HEM-c~-) /rte composite discs, but not in the case of the discs sliced from the 50/50 p(HEIyIA°co-I~IA)/MMA composite rods. However, after these lathed discs were hydrated in water, the center core portion could ba easily pushed out or eliminated from the sheath portion. Therefore, a composite intraocular lens manufactured according to this example would not perform in accordance with the teachings of the present invention.
EXI~klPLE TII
The experiment described in Example I was repeated using both pHEMA and ?5/25 p (HE2~-co-MP3A) ~~~~3~~
- l~ -central core rods containing no crosslinker. In this example, the sheath casting solutions that were placed in the molds surrounding the core rods were solutions of MMA and HEMA at 90/10 and 80/20 mol ratios of MMA to HEMA (no added crosslinker). The composite rods were cured in the standard cure method of Example I. The cured rods were sliced into discs and, from the discs, intraocular lens were made using standard lathing and milling techniques having a central soft optic portion and harder, stiffer blue haptic portions. The lenses were hydrated in distilled water and the blue haptics were found to be securely joined to the clear optic portion of the lens in the case of the 75/25 p(HEMA-co-MMA) core rods, but not in the case of the pHEMA core rods.
EXAMPLE IV
Core rods (0.40 inch diameter) made from the pHEMA of Examples I and II, crosslinked with l mol percent TEGDMA, were immersed in distilled HEMA at room temperature and the average increase in diameter of the rods was measured with calipers at various intervals as shown in Table I below.
TABLE Z
Immersion Time Diameter Increase (in days) (inches) 1 0.003 2 0.005 22 0.010 The 22-day-swelled rods were subsequently made into composite rods with a PMMA sheath including an EGDMA
(1.0 park) crosslinker, AIBId (9.05 parts) initiator, and D & C Green No. 6 dye (0.10 parts). The cured rods were sliced into discs and hydrated as described previously. The blue PMMA haptic portion was faund to adhere strongly to the colorless pHEMA central optic portion .as determined by pull tests. No failures occurred at the pHEMA/PMMA interface.
EXAMPLE V
This experiment was conducted to determine the effect of pore surface area on adherence of the sheath polymeric material. Copolymer core rods, made l0 from a 70/30 mol ratio of HEMA and 6-hydroxyhexyl methacrylate (HOHEXMA) or p(HEMA-co-HOHEXMA) and crosslinked with 3 mol percent of triethylene glycol dimethacrylate (TE~DMA) plus 1,6-hexanediol dimethacrylate, were turned on a lathe to a diameter of 0.375 inches. One of the lathed cores was allowed to swell in water overnight and was subsequently freeze-dried. A second lathed core was wiped with an acetone-damp cloth prior to being centered in the mold.
A third core was used as cash (not lathed). MMA (100 parts by weight) containing EGDMA (1.0 part), AIBN
(0.05 parts) , and D & C Green Na. 6 (0.10 parts) were cast around each core as in Example I. The aura conditions were similar to those of Example I: The cured rods were sliced into discs 1-3 mm thick and imanersed in water to test the integrity of the inter_ face. The two polymeric zones ware strongly bonded together in all three cases.
EPLE VI
Three 70/30 mol ratio p(HEMA-co-HOHEXMA) core rods that had been prwiously lathed to 0.375 inch diameter were allowed to soak in distilled HEMA far 22 hours at room temperature. The excess HEMA was blotted off and the cores were centered in polypropylene test tubes using polypropylene spacegs as described in 1g -Example T. A solution of MMA (100 parts by weight), EG~rla ( 1 part) , Alan ( o . 05 parts ) , ana n & c green r~o .
6 (0.10 parts) was poured around the cores and the sealed molds were cured in a similar fashion to Example 1. The cured rods were turned down on a lathe to 16.4 mm diameter and sliced into 3 mm thick discs. The discs were checked for concentricity and those discs having a clear, central optic portion perfectly cen-tered in the composite disc were made into one-piece l0 composite intraocular lenses of a design similar to Figs. 1 and 2. In hydrated form, the lenses could be folded repeatedly without damaging the clear, foldable optic portion or the colored, non-foldable haptic portions of the lens. Pull or tensile tests (discussed below) established that the PMMA haptic region was strangly affixed to the hydrogel core.
EXAMPLE VII
Example VT was repeated, however, in this example the 70/30 mol ratio p(HEMA-co-HOHEXMA) core rods were allowed to soak in distilled HEMA for 48 hours at room temperature prior to casting in the MMA
solution of Example V: The rods were cured in both the standard way as shown in Example I and in an accelerat ed manner wherein the tubes were suspended in a water bath being tamped from 41°C to 61°C for 3 hours and then held at 61o far 24 hours. The tubes were removed from the bath and further cured in a forced-air oven at 113oc for 38 hours. One Core rod Was cast into .a composite using a sheath solution of MMA/HEMA (l00 parts by weight, g5/5 mol ratio), EGDMA (1 part), AI~PI
(0.05 parts) and n & C Green No. 6 (0.10 parts) under the accelerated cure condition discussed above. The cured rods were machined into one-piece intraocular lenses as shown in Figs. 1 and 2 and, subsequently, i I
hydrated. No qualitative differences could be seen in the strength of the interface between the rods cured under the standard or accelerated conditions in the cases wherein the sheath solution was the I~IA solution 5 of Example V. However, failure at the interface was noted in blanks cut from the rod wherein the sheath solution was the 95/5 mol ratio MrIA/HEMA.
]F~X~M~LE VIII
Y
Three 70/30 mot ratio p(HEMA-co-HOHEXMA) core rods were lathed to 0.236 inch diameter (6.0 mm).
These rods were not preswelled. -The rods were centered in PyreX molds. A sheath solution of 100 parts l~iA, ' 1.0 parts EGDMA, 0.05 parts AIBN, and 0.10 parts D & C
15 Green No. 6 was poured into the mold which was then sealed as discussed above. The rods were cured in accordance with this accelerated method as described in Example VI. The cured rods were sliced into lens blanks. Composite intraocular lenses having a 6 mm 20 diameter central optic portion were fashioned from the lens blanks as is well known in the art. The lenses were hydrated and the strength of the hydrogel/PMMA
interface was found to be strong.
Table 2 below depicts the results of Examples I through VIII:
2Q~83~
,ga W N F-' O
0 0~ o~
J~: Jr. V ~l~'. w)~ J~.171~.
1 v v s ~~O~O~ ~ W ~ ~ ..~. .Or ~L'f' ,~,, v ~':v~
z x N N z z z z z ~'1 ° ~1 ° N
~~~~
m @~ nn ~
~ co m .-...: ..:,.
W W
N N !-' 1-' O O O O
vv vv ~ 22 ~~~$36~G
w ~ cu s~ n ax w a, N -~ ~ ~ O
O h' tOJI W WN
Ov In d K ~c o' N
~b ob ab n~u ~b ~ ;° o ... .~ ....
''f~' N
2~~~3~a EXAMPLE TX
TENSILE TEST
Copolymer core rods were prepared from 5 different mol ratios of HEMA to HOHEXMA; 70/30, 75/25, 80/20, 85/15, and 90/10, each having 3 mol percent of hexanediol dimethacrylate (HDDM) crosslinker. Three methods of forming the composite rods were utilized for this Example (A, H and C).
Method A utilized cores which were 6.0 mm (0.236 inches) in diameter. The cores were preswelled for 24 hours in HEMA. The tubes were suspended in a water bath ranging from 40 to 60oC for 3 hours, held at 60oC for 26.5 hours, removed from the bath, and further cured in a forced-air aven at 110oC far 42 hours.
Method H utilized core rods of the 5 differ-ent mol ratios by allowing the cores to stand at 40°C
for 21 hours, prior to affecting cure by ramping the temperature to 60°C. This is equivalent to the stan-dard cure conditions specified in Examples I-III and VI.
Method C utilized core rods prepared by the accelerated pure conditions as shown in Example VIII.
In all threw methods, the sheathing material is PMMA
formulated as disclosed in the previous examples.
All samples were milled into rectangular slivers approximately 0:17 to 0.18 mm square, and 12 mm in length. Each sliver contained a blue (PMMfA) and clear (hydrogel) region of unequal area. Hoth hydrated (distilled water) (Table 3) and nonhydr~ted (Table 4) specimens wars pulled apart using a pull tester and both the forge at break and the lacation of the break was noted.
The tensile strengths were determined by dividing the force at the break by~ the cross-sectional urea. The break locations were divided into four regions the blue PMt~IA region, the clear hydrogel 2~~~~ ~~' _ 24 °
region, the interfacial region (fragments contain both colors), and the interfacial line (all blue and all clear fragments).
!I 3 PITS TEST RESULTS ° SITE ~Ah Hydrated in distilled water to ~_____ I I I
I~ATZ~1 I
I T~1SILE I I
'p4~) I I I I ~ Iii .
p~ ~TZas I r~~oy t) I ~ I zna~ ~iort I ~~or~ I
70/30 A 1.4 5o. a% 20.0% 20.0% lo.
o%
75/25 A 1.6 9.0% 55.0% 9.0% 27.0%
80/20 A 1.4 18.2% 27.3% 9.0% 45.5%
85/15 A 1.7 10.0% 50.0% 10.0% 30.0%
90/10 A 1.5 20.0% 40.0% 7Ø0% 30.0%
70/30 B 1.3 22.0% 78.0% -_ ""
75/25 H 1.4 - 45.4% 27.3% 27.3%
80/20 H 1.4 18.2% 27.3% 36.3% 18.2%
85/1,5 H 1.5 30.0% 10.0% 20.0% 40,0%
90/10 B 1.5 22.0% 78.0% _ -2 70/30 C 1.5 43.0% -- 14.0% 43.0%
75/25 C 1.9 -- 60.0% 10.0% 30.0%
80/20 C 1.3 12.5% 50.0% 12.5% 25.0%
85/15 C 1.2 31.0% 15.0% 31.0% 23.0%
90/10 C 1.4 20.0% 40.0% 20.0% 20.0%
20~~3~,0 _ 25 _ TA'8L~ 4 ~ TEST - TTE MATERIAL
Nonhydrated -.-- ___..
C~FtE j j ( ( I SOZI~OId I . I ( ELK I~ATIOrI ( I ~ (-~- I I Ti~sz~ j I
~ I $I I nrr~I xx~cy ir~L gas I May ~2) I ~z~ I LINE ~r pcioN I
70/30 .~ 9.3 27.3% 9.0% 27.3% 36.4%
75/25 .A 9.1 60:0% - 10.4% 30.0%
2 0 80/20 A 7.9 50. 0% -'-- 10. 0% 40. 0% , 85/15 A: 9.5 67. Q% ~-- - 33.0%
90/10 A 8:9 33.3% 22.2% 44:5%
70/30 E 9.3 50.0% w-- -- 50.0%
75/25 B 8.4 45.4% --- 36.3% 18.2%
8Q/20 B 7.3 80.0% --- 10.0% 10: Q%
85/15 B 8.9 67.0$ -- 33.0%
90/10 B 8.8 62.5% 12.5% 12.5% 12:5%
70/30 C 9.2 57.0% --- -- 43.0%
75/25 C 9.6 67.0% --- 11.0% 22.0%
3 0 80/20 C 7. 3 37 . 5% 37 . 25 0 0%
5%
85/15 C 7.1 6?:0% - 31:0% 23.0%
90/10 C g.0 56:0% '-" 8.0% 25.0%
- 2s _ In the nonhydrated condition (Table 4), the tensile strength values are consistent with those expected for pure PT~lA or nonhydrated hydrogel. Only a small percentage of the breaks occurred at the interfacial line, indicating that the adhesion of the two materials is excellent.
The tensile strength values of the hydrated slivers are much lower which .is not unexpected as the . tensile strength of the hydrogel portions should decrease with increasing water content. However, no obvious decrease in tensile strength is seen between the various, p(HEP3~r-co~HOHE7~tA) mot ratios. As can be seen in Table 3, a greater percentage of failures occur at the interfacial line as compared to the dry speci-mans. This might be the penult of stress brought about by the proximity of regions of vastly different aqueous expansion coefficient. However, the average tensile strength at break was not found to be significantly lower in specimens that broke'at the interface line.
I~ should also be ruled that no mayor differ-ences in tensile strength or in the location of break were noted between Method A, B or C of composite curing methods. Therefore, all 3 methods represent viable ways to prepare the composite intraacular lenses.
The embodiments above are intended to be illustrative of the invention, and it is expected, that those of ordinary skill in the art may, in view of the teachings contained hereinabove, be able to modify the embodiments illustrated herein. It is intended to lower all such modifications which fell ~withir~ the spirit and scope of the Invention as defined by the claims appended hereto.
Claims (20)
1. A one-piece bicomposite intraocular lens capable of being inserted into an eye through an incision which is smaller than the diameter of the lens, comprising:
a central, soft foldable optic portion of a high refractive index material capable of being folded by an ophthalmic surgeon during the process of inserting the lens during eye surgery; and a hard, stiff haptic portion of a relatively hard non-hydrogel plastic material formed about the outermost peripheral surface of said central optic portion for supporting said lens within the eye whereby said hard plastic material is joined to the periphery of the soft material by means of an interpenetrating polymer network to form a one-piece intraocular lens.
a central, soft foldable optic portion of a high refractive index material capable of being folded by an ophthalmic surgeon during the process of inserting the lens during eye surgery; and a hard, stiff haptic portion of a relatively hard non-hydrogel plastic material formed about the outermost peripheral surface of said central optic portion for supporting said lens within the eye whereby said hard plastic material is joined to the periphery of the soft material by means of an interpenetrating polymer network to form a one-piece intraocular lens.
2. The intraocular lens, according to claim 1, wherein the soft, foldable optic portion is clear and the hard haptic portion is colored.
3. The intraocular lens, according to claim 1 or 2, wherein the material of the soft, foldable optic portion is a hydrogel polymer of hydroxyethyl methacrylate or a copolymer thereof and the material of the haptic portion is a polymer of methyl methacrylate or a copolymer thereof and wherein the polymer of the hydroxyethyl methacrylate is preswelled with hydroxyethyl methacrylate prior to polymerization with the methyl methacrylate.
4. The intraocular lens, according to claim 1 or 2, wherein the material of the soft, foldable optic portion is a copolymer of hydroxyethyl methacrylate and 6-hydroxyhexyl methacrylate and the material of the haptic portion is a polymer of methyl methacrylate, or a copolymer thereof.
5. The intraocular lens, according to claim 1 or 2, wherein the material of the soft, foldable optic portion is a hydrogel copolymer selected from the group consisting of:
HEMA/N-vinylpyrrolidone;
2,3-dihydroxypropyl methacrylate/methyl methacrylate;
HEMA/N-vinylpyrrolidone/methyl methacrylate;
HEMA/methacrylic acid;
HEMA/2-ethoxyethyl methacrylate;
HEMA/methacrylic acid/isobutyl methacrylate;
hydroxypropyl methacrylamide/methyl methacrylate;
HEMA/n-butyl methacrylate;
HEMA/n-hexyl methacrylate;
HEMA/n-octyl methacrylate;
HEMA/hydroxyoctyl methacrylate;
dimethyl acrylamide/diethyl acrylamide;
HEMA/n-hexyl acrylate; and HEMA/hydroxypropyl methacrylate, and the material of the haptic portion is a polymer of methyl methacrylate, or a copolymer thereof.
HEMA/N-vinylpyrrolidone;
2,3-dihydroxypropyl methacrylate/methyl methacrylate;
HEMA/N-vinylpyrrolidone/methyl methacrylate;
HEMA/methacrylic acid;
HEMA/2-ethoxyethyl methacrylate;
HEMA/methacrylic acid/isobutyl methacrylate;
hydroxypropyl methacrylamide/methyl methacrylate;
HEMA/n-butyl methacrylate;
HEMA/n-hexyl methacrylate;
HEMA/n-octyl methacrylate;
HEMA/hydroxyoctyl methacrylate;
dimethyl acrylamide/diethyl acrylamide;
HEMA/n-hexyl acrylate; and HEMA/hydroxypropyl methacrylate, and the material of the haptic portion is a polymer of methyl methacrylate, or a copolymer thereof.
6. The intraocular lens according to claim 1 or 2, wherein the material of the soft, foldable optic portion is a non- or low-water-containing, low Tg, acrylic homo- or copolymer or silicone-based polymer.
7. A method for making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of:
forming a core of a high refractive material suitable for use as an intraocular lens optic;
swelling said core;
polymerizing about said core a polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a composite rod; and machining said composite rod to form said composite intraocular lens having an optic portion and a haptic portion.
forming a core of a high refractive material suitable for use as an intraocular lens optic;
swelling said core;
polymerizing about said core a polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a composite rod; and machining said composite rod to form said composite intraocular lens having an optic portion and a haptic portion.
8. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 7, wherein said method further comprises the steps of:
positioning said core in a mold; and placing said polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core prior to polymerizing said polymerizable material.
positioning said core in a mold; and placing said polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core prior to polymerizing said polymerizable material.
9. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 7 or 8, wherein swelling of said core comprises applying a swelling agent to said core.
10. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 9, wherein said high refractive material suitable for use as an intraocular lens optic is poly(hydroxyethyl methacrylate), wherein said swelling agent is hydroxyethyl methacrylate, and wherein said polymerizable material capable of forming said haptic portion is poly(methyl methacrylate).
11. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 7 or 8, wherein swelling of said core comprises adding a polymerizable swelling agent to said polymerizable material capable of forming said haptic portion, said polymerizable swelling agent having a capacity to swell said core.
12. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 7 or 8, wherein swelling of said core comprises adding a comonomer of said high refractive material suitable for use as an intraocular lens optic to said high refractive material suitable for use as an intraocular lens optic, said comonomer having a capacity to induce swelling of said core when said polymerizable material capable of forming said haptic portion is polymerized.
13. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with any one of claims 7 to 12, wherein said high refractive material suitable for use as an intraocular lens optic is poly(hydroxyethyl methacrylate).
14. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with any one of claims 7 to 9, 11 and 12, wherein said high refractive material suitable for use as an intraocular lens optic is selected from a group consisting of:
poly(hydroxyethyl methacrylate);
hydroxyethyl methacrylate/6-hydroxyhexyl methacrylate/ethylene glycol dimethacrylate; and hydroxyethyl methacrylate/6-hydroxyhexyl methacrylate/1,6-hexanediol dimethacrylate.
poly(hydroxyethyl methacrylate);
hydroxyethyl methacrylate/6-hydroxyhexyl methacrylate/ethylene glycol dimethacrylate; and hydroxyethyl methacrylate/6-hydroxyhexyl methacrylate/1,6-hexanediol dimethacrylate.
15. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with any one of claims 7 to 9, 11 and 12, wherein said high refractive material suitable for use as an intraocular lens optic is selected from a group consisting of:
hydroxyethyl methacrylate/N-vinylpyrrolidone;
2,3-dihydroxypropyl methacrylate/methyl methacrylate;
hydroxyethyl methacrylate/N-vinylpyrrolidone/methyl methacrylate;
hydroxyethyl methacrylate/methacrylic acid;
hydroxyethyl methacrylate/2-ethoxyethyl methacrylate;
hydroxyethyl methacrylate/methacrylic acid/isobutyl methacrylate;
hydroxypropyl methacrylamide/methyl methacrylate;
hydroxyethyl methacrylate/n-butyl methacrylate;
hydroxyethyl methacrylate/n-hexyl methacrylate;
hydroxyethyl methacrylate/n-octyl methacrylate;
hydroxyethyl methacrylate/hydroxyoctyl methacrylate;
dimethyl acrylamide/diethyl acrylamide;
hydroxyethyl methacrylate/n-hexyl acrylate; and hydroxyethyl methacrylate/hydroxypropyl methacrylate.
hydroxyethyl methacrylate/N-vinylpyrrolidone;
2,3-dihydroxypropyl methacrylate/methyl methacrylate;
hydroxyethyl methacrylate/N-vinylpyrrolidone/methyl methacrylate;
hydroxyethyl methacrylate/methacrylic acid;
hydroxyethyl methacrylate/2-ethoxyethyl methacrylate;
hydroxyethyl methacrylate/methacrylic acid/isobutyl methacrylate;
hydroxypropyl methacrylamide/methyl methacrylate;
hydroxyethyl methacrylate/n-butyl methacrylate;
hydroxyethyl methacrylate/n-hexyl methacrylate;
hydroxyethyl methacrylate/n-octyl methacrylate;
hydroxyethyl methacrylate/hydroxyoctyl methacrylate;
dimethyl acrylamide/diethyl acrylamide;
hydroxyethyl methacrylate/n-hexyl acrylate; and hydroxyethyl methacrylate/hydroxypropyl methacrylate.
16. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with any one of claims 7 to 15, wherein said machining of said composite rod comprises cutting a disc from said composite rod and removing material from said outer layer of said composite rod to form at least one haptic portion of said composite intraocular lens.
17. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with any one of claims 7 to 16, wherein said method further comprises adding a polyfunctional crosslinking agent and an initiator to said high refractive material suitable for use as an intraocular lens optic and adding a polyfunctional crosslinking agent and an initiator to said polymerizable material capable of forming said haptic portion.
18. A method for making a composite intraocular lens having an optic portion and a haptic portion, said method comprising the steps of:
forming a core of a high refractive material suitable for use as an intraocular lens optic, said high refractive material comprising a copolymer of hydroxyethyl methacrylate and a comonomer of hydroxyethyl methacrylate;
swelling said core;
positioning said core in a mold;
placing a polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core;
polymerizing said polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a one-piece rod; and machining said one-piece rod to form said composite intraocular lens having an optic portion and a haptic portion.
forming a core of a high refractive material suitable for use as an intraocular lens optic, said high refractive material comprising a copolymer of hydroxyethyl methacrylate and a comonomer of hydroxyethyl methacrylate;
swelling said core;
positioning said core in a mold;
placing a polymerizable material capable of forming said haptic portion of said composite intraocular lens in said mold about said core;
polymerizing said polymerizable material capable of forming said haptic portion to form an outer layer about said core, whereby said outer layer is bonded to said core, said outer layer and said core forming a one-piece rod; and machining said one-piece rod to form said composite intraocular lens having an optic portion and a haptic portion.
19. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 18, wherein said polymerizable material capable of forming said haptic portion is poly(methyl methacrylate).
20. A method for making a composite intraocular lens having an optic portion and a haptic portion in accordance with claim 18 or 19, wherein said monomer of hydroxyethyl methacrylate is 6-hydroxyhexyl methacrylate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/634,919 | 1990-12-27 | ||
US07/634,919 US5217491A (en) | 1990-12-27 | 1990-12-27 | Composite intraocular lens |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2058350A1 CA2058350A1 (en) | 1992-06-28 |
CA2058350C true CA2058350C (en) | 2003-05-27 |
Family
ID=24545682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002058350A Expired - Lifetime CA2058350C (en) | 1990-12-27 | 1991-12-23 | Composite intraocular lens and method of manufacture |
Country Status (9)
Country | Link |
---|---|
US (2) | US5217491A (en) |
EP (1) | EP0492126B1 (en) |
JP (1) | JP3342031B2 (en) |
AT (1) | ATE162066T1 (en) |
AU (1) | AU649758B2 (en) |
BR (1) | BR9105630A (en) |
CA (1) | CA2058350C (en) |
DE (1) | DE69128703T2 (en) |
ES (1) | ES2110973T3 (en) |
Families Citing this family (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5316704B1 (en) * | 1992-09-28 | 1996-05-21 | Kabi Pharmacia Ophthalmics Inc | Process for fabricating full sized expansible hydrogel intraocular lenses |
US5480950A (en) * | 1992-09-28 | 1996-01-02 | Kabi Pharmacia Ophthalmics, Inc. | High refractive index hydrogels and uses thereof |
US5282853A (en) * | 1992-09-29 | 1994-02-01 | Iolab Corporation | Intraocular lens with resilient haptics |
US5331073A (en) * | 1992-11-09 | 1994-07-19 | Allergan, Inc. | Polymeric compositions and intraocular lenses made from same |
US5571177A (en) * | 1993-06-14 | 1996-11-05 | Allergan | IOL structured for post-operative re-positioning and method for post-operative IOL re-positioning |
JP2776273B2 (en) * | 1994-01-31 | 1998-07-16 | 日本電気株式会社 | Monomer having vinyl group |
US5439950A (en) * | 1994-06-27 | 1995-08-08 | Kabi Pharmacia Ophthalmics, Inc. | Water miscible non-hydrolyzable cross-linkers and high refractive index hydrogels prepared therewith |
US5762836A (en) * | 1994-10-14 | 1998-06-09 | W.K. & Associes | Method for making an intraocular implant with a soft lens |
US5716403A (en) * | 1995-12-06 | 1998-02-10 | Alcon Laboratories, Inc. | Single piece foldable intraocular lens |
US6132462A (en) * | 1995-12-22 | 2000-10-17 | Santen Pharmaceutical Co., Ltd. | Copolymers formed from three components and intraocular lenses made thereof |
FR2744908B1 (en) * | 1996-02-20 | 1998-06-12 | W K Et Associes | MYOPIC INTRAOCULAR IMPLANT |
EP0901354B1 (en) * | 1996-05-17 | 2004-03-17 | Helmut Payer | An ocular implant |
FR2757065B1 (en) * | 1996-12-17 | 1999-03-05 | Corneal Ind | INTRAOCULAR LENS FLEXIBLE IN HYDROPHILIC ACRYLIC MATERIAL AND PREPARATION THEREOF |
DE19738345C1 (en) | 1997-09-02 | 1999-05-06 | Mdp Medical Device Polymers Gm | intraocular lens |
JP3779801B2 (en) * | 1997-09-12 | 2006-05-31 | 株式会社メニコン | Manufacturing method of intraocular lens |
WO1999027978A1 (en) * | 1997-12-02 | 1999-06-10 | Hoya Healthcare Corporation | Intraocular lenses and process for producing molded-in type intraocular lenses |
FR2773705B1 (en) * | 1998-01-21 | 2000-05-26 | Corneal Ind | INTRAOCULAR IMPLANT WITH FLEXIBLE OPTICS AND RIGID HAPTICS |
US6267784B1 (en) | 1998-05-01 | 2001-07-31 | Benz Research And Development Corporation | Intraocular lens and haptics made of a copolymer |
US6096799A (en) * | 1998-05-07 | 2000-08-01 | Benz Research & Development Corporation | Contact lens of high water content and high water balance |
US6217171B1 (en) | 1998-05-26 | 2001-04-17 | Novartis Ag | Composite ophthamic lens |
US6468306B1 (en) | 1998-05-29 | 2002-10-22 | Advanced Medical Optics, Inc | IOL for inhibiting cell growth and reducing glare |
US6884262B2 (en) * | 1998-05-29 | 2005-04-26 | Advanced Medical Optics, Inc. | Enhanced intraocular lens for reducing glare |
FR2779940B1 (en) * | 1998-06-19 | 2000-11-03 | Ioltechnologie Production | IMPLANT FORMING INTRAOCULAR MONOBLOCK BI-MATERIAL |
WO2000002937A1 (en) * | 1998-07-08 | 2000-01-20 | Sunsoft Corporation | Interpenetrating polymer network hydrophilic hydrogels for contact lens |
US6228115B1 (en) | 1998-11-05 | 2001-05-08 | Bausch & Lomb Surgical, Inc. | Intraocular lenses with improved axial stability |
US6329485B1 (en) | 1998-12-11 | 2001-12-11 | Bausch & Lomb Incorporated | High refractive index hydrogel compositions for ophthalmic implants |
EP1035142A1 (en) * | 1999-03-09 | 2000-09-13 | Nidek Co., Ltd. | Acrylic copolymer materials suitable for ophthalmic devices |
FR2790944B1 (en) * | 1999-03-17 | 2001-06-01 | Biotech | FLEXIBLE INTRAOCULAR LENS AND PROCESS FOR OBTAINING |
US6281319B1 (en) | 1999-04-12 | 2001-08-28 | Surgidev Corporation | Water plasticized high refractive index polymer for ophthalmic applications |
US8247511B2 (en) * | 1999-04-12 | 2012-08-21 | Advanced Vision Science, Inc. | Water plasticized high refractive index polymer for ophthalmic applications |
US6190410B1 (en) | 1999-04-29 | 2001-02-20 | Bausch & Lomb Surgical, Inc. | Intraocular lenses |
US6200344B1 (en) * | 1999-04-29 | 2001-03-13 | Bausch & Lomb Surgical, Inc. | Inraocular lenses |
US20060238702A1 (en) | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
US6200342B1 (en) * | 1999-05-11 | 2001-03-13 | Marie-Jose B. Tassignon | Intraocular lens with accommodative properties |
US6461384B1 (en) | 1999-06-17 | 2002-10-08 | Bausch & Lomb Incorporated | Intraocular lenses |
AU6100700A (en) * | 1999-07-16 | 2001-02-05 | Wesley-Jessen Corporation | Thermoformable ophthalmic lens |
AU2004229073B2 (en) * | 1999-07-29 | 2006-09-21 | Bausch & Lomb Incorporated | Intraocular lenses |
US6685741B2 (en) * | 1999-07-29 | 2004-02-03 | Bausch & Lomb Incorporated | Intraocular lenses |
US6271281B1 (en) * | 1999-08-26 | 2001-08-07 | Medennium, Inc. | Homopolymers containing stable elasticity inducing crosslinkers and ocular implants made therefrom |
US20020087210A1 (en) * | 1999-09-02 | 2002-07-04 | Donald Carrol Stenger | Intraocular |
US6767363B1 (en) * | 1999-11-05 | 2004-07-27 | Bausch & Lomb Surgical, Inc. | Accommodating positive and negative intraocular lens system |
US6398809B1 (en) | 2000-04-12 | 2002-06-04 | Bausch & Lomb Incorporated | Intraocular lens |
US6555030B1 (en) | 2000-04-21 | 2003-04-29 | Advanced Medical Optics, Inc. | Method for making an accommodating intraocular lens |
US6425917B1 (en) | 2000-05-12 | 2002-07-30 | Tekia | Phakic iol film frame |
BR0111162A (en) * | 2000-05-15 | 2003-04-08 | Bausch & Lomb | Iris-attached injectable intraocular lens |
AUPQ765200A0 (en) * | 2000-05-19 | 2000-06-15 | Oversby Pty Ltd | Intraocular lens implants |
US20020072796A1 (en) | 2000-12-11 | 2002-06-13 | Hoffmann Laurent G. | Iris fixated intraocular lenses |
US6558420B2 (en) | 2000-12-12 | 2003-05-06 | Bausch & Lomb Incorporated | Durable flexible attachment components for accommodating intraocular lens |
US8486140B2 (en) * | 2001-01-30 | 2013-07-16 | Timothy R. Willis | Refractive intraocular implant lens and method |
US20070142912A1 (en) * | 2001-01-30 | 2007-06-21 | Willis Timothy R | Refractive intraocular implant lens and method |
US20020173845A1 (en) * | 2001-05-21 | 2002-11-21 | Bandhauer Mark H. | Low surface-glare intraocular lenses |
US20030055499A1 (en) | 2001-09-14 | 2003-03-20 | Nguyen Tuan Anh | Low profile intraocular lenses |
FR2831423B1 (en) | 2001-10-31 | 2004-10-15 | Bausch & Lomb | INTRAOCULAR LENSES PROVIDED WITH ANGULAR EDGES IN ORDER TO AVOID POSTERIOR CAPSULAR OPACIFICATION |
US6730767B2 (en) | 2001-11-02 | 2004-05-04 | Bausch & Lomb Incorporated | High refractive index aromatic-based siloxane monofunctional macromonomers |
US6723816B2 (en) | 2001-11-02 | 2004-04-20 | Bausch & Lomb Incorporated | High refractive index aromatic-based siloxane difunctional macromonomers |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US7179292B2 (en) * | 2002-03-15 | 2007-02-20 | Ophtec B.V. | Intraocular lens for implantation in an eye and instrument and methods for insertion of such a lens |
US20030223954A1 (en) * | 2002-05-31 | 2003-12-04 | Ruscio Dominic V. | Polymeric materials for use as photoablatable inlays |
US6737448B2 (en) * | 2002-06-03 | 2004-05-18 | Staar Surgical Company | High refractive index, optically clear and soft hydrophobic acrylamide copolymers |
US7270678B2 (en) * | 2002-06-28 | 2007-09-18 | Bausch & Lomb Incorporated | Surface modification of functional group-containing medical devices with catalyst-containing reactive polymer system |
US7083646B2 (en) * | 2002-06-28 | 2006-08-01 | Bausch & Lomb Incorporated | Surface modification of functional group-containing intraocular lenses |
FR2841770B1 (en) * | 2002-07-05 | 2004-10-01 | Ioltechnologie Production | MEATIC NAIL FOR SHUTTERING A LACRYMAL MEAT |
US20040068317A1 (en) * | 2002-10-07 | 2004-04-08 | Knight Patricia M. | Anterior chamber intraocular lens with size and position indicators |
US7662180B2 (en) | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
US6956087B2 (en) * | 2002-12-13 | 2005-10-18 | Bausch & Lomb Incorporated | High refractive index polysiloxane prepolymers |
US20040119175A1 (en) * | 2002-12-20 | 2004-06-24 | Reed Bryan M. | Apparatus and method for manufacturing intraocular lenses |
US20040153150A1 (en) * | 2003-01-30 | 2004-08-05 | Advanced Medical Optics, Inc. | Composite anterior chamber intraocular lens and method of manufacture thereof |
US7303582B2 (en) * | 2003-03-21 | 2007-12-04 | Advanced Medical Optics, Inc. | Foldable angle-fixated intraocular lens |
US20060052869A1 (en) * | 2003-06-26 | 2006-03-09 | Reed Bryan M | IOL square edge punch and haptic insertion fixture |
WO2005047349A1 (en) * | 2003-11-05 | 2005-05-26 | Benz Research And Development Corporation | Materials for making hydrophobic intraocular lens |
DE10353264B4 (en) * | 2003-11-14 | 2022-07-07 | Carl Zeiss Meditec Ag | Adapter for coupling a laser processing device to an object |
US7615073B2 (en) | 2003-12-09 | 2009-11-10 | Advanced Medical Optics, Inc. | Foldable intraocular lens and method of making |
US7621949B2 (en) | 2003-12-09 | 2009-11-24 | Advanced Medical Optics, Inc. | Foldable intraocular lens and method of making |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
US20050187621A1 (en) * | 2004-02-24 | 2005-08-25 | Brady Daniel G. | Foldable unitary intraocular lens |
US7354980B1 (en) | 2004-03-12 | 2008-04-08 | Key Medical Technologies, Inc. | High refractive index polymers for ophthalmic applications |
US7713745B2 (en) * | 2004-04-13 | 2010-05-11 | Sensors For Medicine And Science, Inc. | Non-covalent immobilization of indicator molecules |
US20070159594A9 (en) * | 2004-05-13 | 2007-07-12 | Jani Dharmendra M | Photochromic blue light filtering materials and ophthalmic devices |
DE102004027236B4 (en) * | 2004-06-03 | 2006-04-13 | Morcher Gmbh | Capsular equatorial ring |
US7455691B2 (en) | 2004-11-03 | 2008-11-25 | Biovision, Ag | Intraocular and intracorneal refractive lenses |
WO2006054130A1 (en) * | 2004-11-19 | 2006-05-26 | Bausch & Lomb Incorporated | Thin iol |
US7446157B2 (en) * | 2004-12-07 | 2008-11-04 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
JP4587825B2 (en) * | 2005-02-01 | 2010-11-24 | 株式会社ニデック | Manufacturing method of intraocular lens |
US7387642B2 (en) * | 2005-04-13 | 2008-06-17 | Benz Research And Development Corporation | Polymers for intraocular lenses |
DE102005040338B4 (en) * | 2005-08-25 | 2019-08-29 | Carl Zeiss Meditec Ag | Contact glass for eye surgery |
FR2891276B1 (en) | 2005-09-28 | 2007-12-21 | Corneal Ind Soc Par Actions Si | COMPOUNDS SUITABLE FOR YELLOW POLYMERIZABLE COLORANTS; POLYMERIZABLE AND / OR CROSS - LINKABLE COMPOSITIONS, POLYMERIC MATRICES AND INTRAOCULAR LENSES REFLECTING THEREOF. |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
JPWO2008041683A1 (en) * | 2006-10-04 | 2010-02-04 | Hoya株式会社 | Soft intraocular lens |
US7713299B2 (en) * | 2006-12-29 | 2010-05-11 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US7993398B2 (en) * | 2007-04-24 | 2011-08-09 | Abbott Medical Optics Inc. | Angle indicator for capsular bag size measurement |
US9216080B2 (en) | 2007-08-27 | 2015-12-22 | Amo Groningen B.V. | Toric lens with decreased sensitivity to cylinder power and rotation and method of using the same |
US8974526B2 (en) | 2007-08-27 | 2015-03-10 | Amo Groningen B.V. | Multizonal lens with extended depth of focus |
US8216310B2 (en) * | 2007-09-28 | 2012-07-10 | Abbott Medical Optics Inc. | Polymer compositions suitable for intraocular lenses and related methods |
KR20100087152A (en) * | 2007-10-10 | 2010-08-03 | 벤즈리써치앤드디벨롭먼트코오포레이숀 | Hydrogel with high water content and stability |
EP2227714B1 (en) | 2007-12-12 | 2013-06-19 | Neoptics AG | Intracorneal lenses having a central hole |
US9156949B2 (en) | 2007-12-21 | 2015-10-13 | Abbott Medical Optics Inc. | Silicone containing polymeric materials |
US8530590B2 (en) * | 2007-12-21 | 2013-09-10 | Abbot Medical Optics Inc. | Soft silicone materials for ophthalmic applications |
US8232363B2 (en) * | 2007-12-21 | 2012-07-31 | Abbott Medical Optics Inc. | Silicone containing polymeric materials |
ATE523810T1 (en) | 2008-02-15 | 2011-09-15 | Amo Regional Holdings | SYSTEM, GLASS LENS AND METHOD FOR EXPANDING THE DEPTH OF FOCUS |
US8439498B2 (en) | 2008-02-21 | 2013-05-14 | Abbott Medical Optics Inc. | Toric intraocular lens with modified power characteristics |
EP2268191B1 (en) | 2008-03-28 | 2013-03-20 | Abbott Medical Optics Inc. | Systems for ocular measurements |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
US8862447B2 (en) | 2010-04-30 | 2014-10-14 | Amo Groningen B.V. | Apparatus, system and method for predictive modeling to design, evaluate and optimize ophthalmic lenses |
US20100082017A1 (en) | 2008-09-26 | 2010-04-01 | Advanced Medical Optics, Inc. | Laser modification of intraocular lens |
SG173450A1 (en) * | 2009-02-20 | 2011-09-29 | Hoya Corp | Soft intraocular lens and method of manufacturing same |
AU2010266022B2 (en) | 2009-06-26 | 2015-04-23 | Johnson & Johnson Surgical Vision, Inc. | Accommodating intraocular lenses |
WO2011017322A1 (en) | 2009-08-03 | 2011-02-10 | Abbott Medical Optics Inc. | Intraocular lens for providing accomodative vision |
US9445889B2 (en) | 2009-09-30 | 2016-09-20 | Abbott Medical Optics Inc. | Capsular membrane implants to increase accommodative amplitude |
US9278026B2 (en) | 2009-09-30 | 2016-03-08 | Abbott Medical Optics Inc. | Capsular membrane treatments to increase accommodative amplitude |
CN102892380B (en) | 2009-12-18 | 2016-10-19 | Amo格罗宁根私人有限公司 | Single micro structure eyeglass, system and method |
US8449611B2 (en) | 2010-04-01 | 2013-05-28 | Bausch & Lomb Incorporated | Intraocular lens |
EP2563275A4 (en) | 2010-04-27 | 2017-11-22 | Lensgen, Inc | Accommodating intraocular lens device |
CN102247222B (en) * | 2010-05-17 | 2015-09-09 | 爱博诺德(北京)医疗科技有限公司 | Soft artificial intraocular lens device |
EP2646872A1 (en) | 2010-12-01 | 2013-10-09 | AMO Groningen B.V. | A multifocal lens having an optical add power progression, and a system and method of providing same |
TWI628196B (en) | 2011-09-16 | 2018-07-01 | 班茲研發公司 | Hydrophobic intraocular lens |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
CA2877203A1 (en) | 2012-12-04 | 2014-06-12 | Amo Groningen B.V. | Lenses, systems and methods for providing binocular customized treatments to correct presbyopia |
US9486311B2 (en) | 2013-02-14 | 2016-11-08 | Shifamed Holdings, Llc | Hydrophilic AIOL with bonding |
US9554891B2 (en) | 2013-03-14 | 2017-01-31 | Amo Groningen B.V. | Apparatus, system, and method for providing an implantable ring for altering a shape of the cornea |
EP2976042B1 (en) | 2013-03-21 | 2023-09-13 | Shifamed Holdings, LLC | Accommodating intraocular lens |
CN103251978A (en) * | 2013-04-18 | 2013-08-21 | 温州医学院眼视光研究院 | Foldable intraocular lens and preparation method thereof |
JP5686486B2 (en) * | 2013-07-01 | 2015-03-18 | Hoya株式会社 | Soft intraocular lens and manufacturing method thereof |
EP3062742B1 (en) | 2013-11-01 | 2021-12-01 | Lensgen, Inc. | Two-part accommodating intraocular lens device |
WO2015066502A1 (en) | 2013-11-01 | 2015-05-07 | Thomas Silvestrini | Accomodating intraocular lens device |
US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
CN110279494B (en) | 2014-08-26 | 2023-02-17 | 施菲姆德控股有限责任公司 | Accommodating intraocular lens |
JP6572311B2 (en) | 2014-09-09 | 2019-09-04 | スター サージカル カンパニー | Ophthalmic implant with extended depth of field and improved distance vision |
US10159562B2 (en) | 2014-09-22 | 2018-12-25 | Kevin J. Cady | Intraocular pseudophakic contact lenses and related systems and methods |
US11109957B2 (en) | 2014-09-22 | 2021-09-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10299910B2 (en) | 2014-09-22 | 2019-05-28 | Kevin J. Cady | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10945832B2 (en) | 2014-09-22 | 2021-03-16 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
CN111281602A (en) | 2015-08-14 | 2020-06-16 | 蒂莫西·R·威利斯 | Intraocular lens (IOL) and related components and methods of intraocular attachment |
US11141263B2 (en) | 2015-11-18 | 2021-10-12 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lens |
WO2017096087A1 (en) | 2015-12-01 | 2017-06-08 | Daniel Brady | Accommodating intraocular lens device |
CN106956082A (en) * | 2016-01-11 | 2017-07-18 | 广东东阳光药业有限公司 | Artificial lens preparation method |
CA3013856A1 (en) | 2016-02-09 | 2017-08-17 | Amo Groningen B.V. | Progressive power intraocular lens, and methods of use and manufacture |
WO2017156077A1 (en) | 2016-03-09 | 2017-09-14 | Staar Surgical Company | Ophthalmic implants with extended depth of field and enhanced distance visual acuity |
EP3432768B1 (en) | 2016-03-23 | 2020-04-29 | Johnson & Johnson Surgical Vision, Inc. | Power calculator for an ophthalmic apparatus with corrective meridians having extended tolerance or operation band |
WO2017165660A1 (en) | 2016-03-23 | 2017-09-28 | Abbott Medical Optics Inc. | Ophthalmic apparatus with corrective meridians having extended tolerance band |
EP3439580A4 (en) * | 2016-04-05 | 2019-11-13 | Sri, Ganesh | Posterior chamber intraocular lens with swivel haptics for capsulotomy fixation |
US10196470B2 (en) | 2016-05-16 | 2019-02-05 | Benz Research And Development Corp. | Hydrophobic intraocular lens |
WO2018078439A2 (en) | 2016-10-25 | 2018-05-03 | Amo Groningen B.V. | Realistic eye models to design and evaluate intraocular lenses for a large field of view |
US10894111B2 (en) | 2016-12-16 | 2021-01-19 | Benz Research And Development Corp. | High refractive index hydrophilic materials |
US10350056B2 (en) | 2016-12-23 | 2019-07-16 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lenses and methods for making and using same |
US10739227B2 (en) | 2017-03-23 | 2020-08-11 | Johnson & Johnson Surgical Vision, Inc. | Methods and systems for measuring image quality |
CO2017004085A1 (en) * | 2017-04-26 | 2018-10-31 | Fundacion Univ Del Norte | Intraocular implant |
WO2018213240A1 (en) | 2017-05-16 | 2018-11-22 | Benz Research And Development Corp. | Micro injectable, low chromatic aberration intraocular lens materials |
WO2018222579A1 (en) | 2017-05-30 | 2018-12-06 | Shifamed Holdings, Llc | Surface treatments for accommodating intraocular lenses and associated methods and devices |
EP3634309B1 (en) | 2017-06-07 | 2023-05-24 | Shifamed Holdings, LLC | Adjustable optical power intraocular lenses |
US10663763B2 (en) | 2017-07-12 | 2020-05-26 | Vision Pro (Wuxi) Ltd | Multifocal intraocular lens |
AU2018330604A1 (en) | 2017-09-11 | 2020-04-02 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
CA3082053A1 (en) | 2017-11-30 | 2019-06-06 | Amo Groningen B.V. | Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof |
WO2019236908A1 (en) * | 2018-06-07 | 2019-12-12 | Lensgen, Inc. | Intraocular lens devices and related methods |
ES2956033T3 (en) | 2018-08-17 | 2023-12-12 | Staar Surgical Co | Polymeric composition exhibiting refractive index nanogradient |
AU2020357870A1 (en) | 2019-10-04 | 2022-04-28 | Alcon Inc. | Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses |
US11886046B2 (en) | 2019-12-30 | 2024-01-30 | Amo Groningen B.V. | Multi-region refractive lenses for vision treatment |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4093361A (en) * | 1971-11-15 | 1978-06-06 | Precision Cosmet Co., Inc. | Composite prosthetic polymeric devices |
JPS5337028B2 (en) * | 1973-12-11 | 1978-10-06 | ||
US4121885A (en) * | 1974-04-29 | 1978-10-24 | Precision Cosmet Co., Inc. | Method to produce a composite contact lens |
US4608049A (en) * | 1982-06-28 | 1986-08-26 | Kelman Charles D | Intraocular lens and method of inserting an intraocular lens into an eye |
US4556998A (en) * | 1983-08-04 | 1985-12-10 | Siepser Steven B | Artificial intraocular lenses and method for their surgical implantation |
US4787904A (en) * | 1984-07-06 | 1988-11-29 | Severin Sanford L | Hydrophillic intraocular lens |
US4702865A (en) * | 1984-09-10 | 1987-10-27 | Koziol Jeffrey E | Method of forming an intraocular lens |
US4615702A (en) * | 1984-09-10 | 1986-10-07 | Koziol Jeffrey E | Intraocular lens and method of forming the lens |
US4774036A (en) * | 1985-08-01 | 1988-09-27 | Dennis T. Grendahl | Method of making an intraocular lens |
US4687485A (en) * | 1985-08-23 | 1987-08-18 | Barnes-Hind, Inc. | Intraocular lens with leg means having compressible regions and/or color |
US4961746A (en) * | 1985-08-23 | 1990-10-09 | American Cyanamid Company | Intraocular lens with colored legs and method of making |
US4834751A (en) * | 1985-12-04 | 1989-05-30 | Allergan, Inc. | Staking ring for soft IOL |
US4978354A (en) * | 1985-12-09 | 1990-12-18 | Allergan, Inc. | Haptic to optic attachment for a soft IOL |
US4718906A (en) * | 1986-03-11 | 1988-01-12 | Mackool Richard J | Intraocular lens |
US4764169A (en) * | 1986-12-04 | 1988-08-16 | Grendahl Dennis T | Intraocular lens |
CS267858B1 (en) * | 1987-01-12 | 1990-02-12 | Sulc Jiri | Contact,if need be,intra-ocular lens and method of its production |
US4813956A (en) * | 1987-04-03 | 1989-03-21 | Ioptex Research, Inc. | Method of forming single-piece intraocular lens and core member and lens formed thereby |
US4932968A (en) | 1987-07-07 | 1990-06-12 | Caldwell Delmar R | Intraocular prostheses |
US4904421A (en) | 1987-11-25 | 1990-02-27 | Tomei Sangyo Kabushiki Kaisha | Soft ocular lens and method for its preparation |
US4936849A (en) * | 1988-03-15 | 1990-06-26 | Minnesota Mining And Manufacturing Company | Intraocular lens |
US4978885A (en) * | 1989-03-02 | 1990-12-18 | Galileo Electro-Optics Corporation | Electron multipliers with reduced ion feedback |
US4997442A (en) * | 1989-05-04 | 1991-03-05 | Alcon Laboratories, Inc. | Bicomposite intraocular lenses |
US5089180A (en) * | 1989-08-31 | 1992-02-18 | Iolab Corporation | Method of preparing composite single-piece intraocular lenses with colored haptics |
US5182053A (en) * | 1990-03-02 | 1993-01-26 | Optical Radiation Corporation | Process for forming intraocular lenses having haptics with high fracture toughness |
US5037435A (en) * | 1990-03-02 | 1991-08-06 | Optical Radiation Corporation | Haptics for intraocular lenses having high fracture toughness |
-
1990
- 1990-12-27 US US07/634,919 patent/US5217491A/en not_active Expired - Lifetime
-
1991
- 1991-11-18 ES ES91119613T patent/ES2110973T3/en not_active Expired - Lifetime
- 1991-11-18 DE DE69128703T patent/DE69128703T2/en not_active Expired - Lifetime
- 1991-11-18 EP EP91119613A patent/EP0492126B1/en not_active Expired - Lifetime
- 1991-11-18 AT AT91119613T patent/ATE162066T1/en not_active IP Right Cessation
- 1991-12-23 CA CA002058350A patent/CA2058350C/en not_active Expired - Lifetime
- 1991-12-24 AU AU90059/91A patent/AU649758B2/en not_active Expired
- 1991-12-24 JP JP35551491A patent/JP3342031B2/en not_active Expired - Lifetime
- 1991-12-27 BR BR919105630A patent/BR9105630A/en unknown
-
1993
- 1993-01-28 US US08/010,373 patent/US5326506A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR9105630A (en) | 1992-09-01 |
JP3342031B2 (en) | 2002-11-05 |
EP0492126A3 (en) | 1993-02-17 |
AU649758B2 (en) | 1994-06-02 |
US5217491A (en) | 1993-06-08 |
ES2110973T3 (en) | 1998-03-01 |
DE69128703T2 (en) | 1998-04-30 |
DE69128703D1 (en) | 1998-02-19 |
US5326506A (en) | 1994-07-05 |
ATE162066T1 (en) | 1998-01-15 |
JPH04295353A (en) | 1992-10-20 |
EP0492126A2 (en) | 1992-07-01 |
AU9005991A (en) | 1992-07-02 |
CA2058350A1 (en) | 1992-06-28 |
EP0492126B1 (en) | 1998-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2058350C (en) | Composite intraocular lens and method of manufacture | |
KR100438477B1 (en) | Intraocular lenses and process for producing molded-in type intraocular lenses | |
US4687485A (en) | Intraocular lens with leg means having compressible regions and/or color | |
AU650156B2 (en) | Keratoprosthesis and method of producing the same | |
CA2055138C (en) | Polymers and their use for flexible intraocular lenses | |
US5403901A (en) | Flexible, high refractive index polymers | |
US6353069B1 (en) | High refractive index ophthalmic device materials | |
US4731079A (en) | Intraocular lenses | |
EP1083844B1 (en) | Intraocular lens | |
US4961746A (en) | Intraocular lens with colored legs and method of making | |
EP1274562B1 (en) | Method for making an accommodating intraocular lens | |
US5147394A (en) | High refractive index polymeric compositions suitable for use as expansile hydrogel intraocular lenses | |
US20070004863A1 (en) | Infinite refractive index gradient (IRIG) polymers for ocular implant and contact lens applications | |
EP1079870B1 (en) | Bicomposite intraocular lens and method for its preparation | |
RU2232561C2 (en) | Intraocular lens with construction for regulating its axial shift after implantation | |
CA2315747C (en) | High refractive index ophthalmic device materials | |
EP1003795B1 (en) | Ophthalmic lens polymers | |
EP1393694A1 (en) | Method of manufacturing intraocular lenses and intraocular lenses manufactured by the method | |
EP1369710B1 (en) | Method of manufacturing intraocular lenses and intraocular lenses manufactured by the method | |
Shoji et al. | Intraocular lens durability after a mean of 10.9 years' implantation in humans | |
MXPA99006837A (en) | Intraocular lenses and process for producing molded-in type intraocular lenses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |